spironolactone has been researched along with Hypokalemia in 250 studies
Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.
Hypokalemia: Abnormally low potassium concentration in the blood. It may result from potassium loss by renal secretion or by the gastrointestinal route, as by vomiting or diarrhea. It may be manifested clinically by neuromuscular disorders ranging from weakness to paralysis, by electrocardiographic abnormalities (depression of the T wave and elevation of the U wave), by renal disease, and by gastrointestinal disorders. (Dorland, 27th ed)
Excerpt | Relevance | Reference |
---|---|---|
"AAs with HF exhibited less hyperkalemia and more hypokalemia with spironolactone compared with non-AAs and seemed to derive less clinical benefit." | 9.17 | Race influences the safety and efficacy of spironolactone in severe heart failure. ( Anand, I; Cavallari, LH; Claggett, B; Desai, AS; Pitt, B; Rossignol, P; Solomon, SD; Vardeny, O; Zannad, F, 2013) |
" Patients who received spironolactone were significantly less likely to experience mild, moderate, or severe hypokalemia (8." | 9.14 | Spironolactone in preventing hypokalemia following traumatic brain injury. ( Abrishamkar, S; Shafiei, M, 2010) |
"The aim of this prospective, randomised, open-label, blinded-end point study was to compare the efficacy and safety of eplerenone versus spironolactone in patients with bilateral idiopathic hyperaldosteronism (IHA)." | 9.13 | Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism. ( Anagnostis, P; Athyros, VG; Kakafika, AI; Karagiannis, A; Mikhailidis, DP; Pagourelias, ED; Papageorgiou, A; Tziomalos, K, 2008) |
" This study was designed to assess the ability of spironolactone to reduce potassium requirements and to prevent hypokalemia in neutropenic patients on AmB treatment." | 9.10 | Spironolactone: is it a novel drug for the prevention of amphotericin B-related hypokalemia in cancer patients? ( Avcu, F; Beyan, C; Cetin, T; Kaptan, K; Nazaroglu, NK; Ural, AU; Yalcin, A, 2002) |
"Spironolactone is safe and effective in treating hypokalemia in PD patients." | 7.85 | Spironolactone is effective in treating hypokalemia among peritoneal dialysis patients. ( Hiremath, S; Langote, A; McCormick, BB; Ruzicka, M, 2017) |
"This paper details the case of a 26-year-old woman with depletion syndrome and the effectiveness of her treatment with indomethacin." | 7.85 | Indomethacin therapy effective in a patient with depletion syndrome from secretory villous adenoma. ( Kagan, MD; Sangha, G; Schmidt, K, 2017) |
" The addition of spironolactone to her previous medications controlled and normalized hypertension, hypokalemia, and hormonal abnormalities within 4 months." | 7.76 | Resistant hypertension in an aged woman presenting with clinical features simulating ectopic ACTH syndrome--response to spironolactone--. ( Harada, E; Mizuno, Y; Morikawa, Y; Nakagawa, H; Saito, Y; Semba, F; Yasue, H; Yoshimura, M, 2010) |
"The Epleronone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) trial demonstrated that selective aldosterone blockade with eplerenone significantly reduced total mortality by 15%, combined cardiovascular (CV) mortality/CV hospitalization by 13%, CV mortality by 17% and sudden cardiac death by 21%, vs." | 7.74 | Eplerenone improves prognosis in postmyocardial infarction diabetic patients with heart failure: results from EPHESUS. ( Abuissa, H; O'Keefe, JH; Pitt, B, 2008) |
"Six adult patients (4 females and 2 males, age range 26-57 years) with Gitelman's syndrome (GS) were treated with spironolactone 200-300 mg/day (n = 5) and/or amiloride 10-30 mg/day (n = 3) for 1-18 months." | 7.69 | Correction of hypokalemia with antialdosterone therapy in Gitelman's syndrome. ( Colussi, G; De Ferrari, ME; Macaluso, M; Minetti, L; Rombolà, G, 1994) |
"A case of primary aldosteronism treated with spironolactone therapy has been followed up for 24 years." | 7.68 | Twenty-four year spironolactone therapy in an aged patient with aldosterone-producing adenoma. ( Hashimoto, T; Ito, Y; Koshida, H; Miyamori, I; Morimoto, S; Morise, T; Takeda, R; Yamazaki, T, 1992) |
"During treatment with indomethacin in a patient with Bartter's syndrome, hypokalemia, high plasma renin concentration, hyperaldosteronism and decreased sensitivity to angiotensin infusion were corrected." | 7.65 | Bartter's syndrome with hyperplasia of renomedullary cells: successful treatment with indomethacin. ( Amery, A; Clement, J; Michielsen, P; van Damme B, B; Verberckmoes, R, 1976) |
"Triamterene therapy was evaluated in 35 patients with congestive heart failure over a period of two and one-half years." | 7.64 | CLINICAL EXPERIENCE WITH A NEW DIURETIC, TRIAMTERENE, IN CONJESTIVE HEART FAILURE. ( LAUFER, ST; MAHABIR, RN, 1964) |
"Indomethacin was the most effective but can cause gastrointestinal intolerance and decreased eGFR." | 6.80 | Indomethacin, amiloride, or eplerenone for treating hypokalemia in Gitelman syndrome. ( Allard, J; Azizi, M; Baron, S; Bergerot, D; Blanchard, A; Bridoux, F; Caumont-Prim, A; Desport, E; Dubourg, L; Essig, M; Monge, M; Tack, I; Vallet, M; Vargas-Poussou, R, 2015) |
"The renal sodium retention in congestive heart failure is a consequence of the activation of the sympathetic nervous system and of the renin-angiotensin-aldosterone system." | 6.41 | [Diuretic therapy in congestive heart failure--new views on spironolactone therapy]. ( Haller, C, 2000) |
"Eplerenone treatment of patients with PA reduces blood pressure, increases serum potassium level, and improves vascular status." | 5.43 | Eplerenone improves carotid intima-media thickness (IMT) in patients with primary aldosteronism. ( Anzai, K; Kawate, H; Matsuda, Y; Matsuzaki, C; Nomura, M; Ohnaka, K; Sakamoto, R; Shibue, K; Takayanagi, R, 2016) |
"These findings were compatible with Gitelman's syndrome (GS)." | 5.38 | Eplerenone improved hypokalemia in a patient with Gitelman's syndrome. ( Ito, Y; Maeda, H; Miyata, M; Nakayama, M; Ogawa, K; Oiso, Y; Tsutaya, S; Yoshida, M, 2012) |
"Rhabdomyolysis is a rare presentation of hypokalemia, although muscle weakness is a well known manifestation of marked hypokalemia." | 5.35 | An unusual case of an aldosterone-producing adrenocortical adenoma presenting with rhabdomyolysis. ( Ahmetoğlu, A; Bahat, E; Imamoğlu, M; Karagüzel, G; Okten, A; Yildiz, K, 2009) |
"We report a rare case of adrenocortical carcinoma." | 5.32 | Co-secretion of aldosterone and cortisol by an adrenocortical carcinoma. ( Azizlerli, H; Kapran, Y; Kurtulmus, N; Yarman, S, 2004) |
"Treatment with spironolactone alone for 2 months corrected hypertension, hypokalemic alkalosis, and all laboratory and radiologic evidence of rickets and hyperparathyroidism, resulting in acceleration of growth rate." | 5.27 | Spironolactone-reversible rickets associated with 11 beta-hydroxysteroid dehydrogenase deficiency syndrome. ( Arnhold, IJ; Batista, MC; Bloise, W; Kater, CE; Mendonça, BB; Nicolau, W; Rocha, A, 1986) |
"With appropriate surveillance of potassium and creatinine, the use of spironolactone was associated with less hypokalemia and improved survival in patients with severe heart failure even in the setting of moderate hyperkalemia." | 5.19 | Incidence, predictors, and outcomes related to hypo- and hyperkalemia in patients with severe heart failure treated with a mineralocorticoid receptor antagonist. ( Anand, I; Claggett, B; Desai, AS; Pitt, B; Rossignol, P; Solomon, SD; Vardeny, O; Zannad, F, 2014) |
"AAs with HF exhibited less hyperkalemia and more hypokalemia with spironolactone compared with non-AAs and seemed to derive less clinical benefit." | 5.17 | Race influences the safety and efficacy of spironolactone in severe heart failure. ( Anand, I; Cavallari, LH; Claggett, B; Desai, AS; Pitt, B; Rossignol, P; Solomon, SD; Vardeny, O; Zannad, F, 2013) |
" Patients who received spironolactone were significantly less likely to experience mild, moderate, or severe hypokalemia (8." | 5.14 | Spironolactone in preventing hypokalemia following traumatic brain injury. ( Abrishamkar, S; Shafiei, M, 2010) |
"The aim of this prospective, randomised, open-label, blinded-end point study was to compare the efficacy and safety of eplerenone versus spironolactone in patients with bilateral idiopathic hyperaldosteronism (IHA)." | 5.13 | Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism. ( Anagnostis, P; Athyros, VG; Kakafika, AI; Karagiannis, A; Mikhailidis, DP; Pagourelias, ED; Papageorgiou, A; Tziomalos, K, 2008) |
" This study was designed to assess the ability of spironolactone to reduce potassium requirements and to prevent hypokalemia in neutropenic patients on AmB treatment." | 5.10 | Spironolactone: is it a novel drug for the prevention of amphotericin B-related hypokalemia in cancer patients? ( Avcu, F; Beyan, C; Cetin, T; Kaptan, K; Nazaroglu, NK; Ural, AU; Yalcin, A, 2002) |
"The relative efficacies of potassium chloride, amiloride, triamterene and spironolactone in maintaining potassium balance were studied in 40 patients with essential hypertension receiving diuretic therapy." | 5.04 | Maintenance of potassium balance during diuretic therapy. ( Eisalo, A; Kohvakka, A; Manninen, V, 1979) |
" Compared with placebo, across all eGFR categories, spironolactone was associated with lower relative risk for the primary efficacy outcome and for hypokalemia, but higher relative risk for hyperkalemia, worsening renal function, and drug discontinuation." | 3.91 | Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney Disease. ( Beldhuis, IE; Claggett, B; Damman, K; Desai, AS; Fang, JC; Lewis, EF; Myhre, PL; O'Meara, E; Pfeffer, MA; Pitt, B; Shah, SJ; Solomon, SD; Voors, AA, 2019) |
"This paper details the case of a 26-year-old woman with depletion syndrome and the effectiveness of her treatment with indomethacin." | 3.85 | Indomethacin therapy effective in a patient with depletion syndrome from secretory villous adenoma. ( Kagan, MD; Sangha, G; Schmidt, K, 2017) |
"Spironolactone, which is a potent mineralocorticoid receptor antagonist, represents the first line medical treatment of primary aldosteronism (PA)." | 3.83 | SFE/SFHTA/AFCE consensus on primary aldosteronism, part 7: Medical treatment of primary aldosteronism. ( Herpin, D; Lefebvre, H; Pechère-Bertschi, A, 2016) |
" Hypokalemia and hypomagnesemia in GS were difficult to correct; however, spironolactone might be helpful for hypokalemia to some degree." | 3.83 | Genotype/Phenotype Analysis in 67 Chinese Patients with Gitelman's Syndrome. ( Lang, Y; Liu, T; Lu, J; Shao, L; Wang, C; Zhao, X, 2016) |
" The addition of spironolactone to her previous medications controlled and normalized hypertension, hypokalemia, and hormonal abnormalities within 4 months." | 3.76 | Resistant hypertension in an aged woman presenting with clinical features simulating ectopic ACTH syndrome--response to spironolactone--. ( Harada, E; Mizuno, Y; Morikawa, Y; Nakagawa, H; Saito, Y; Semba, F; Yasue, H; Yoshimura, M, 2010) |
" With the discontinuation of the licorice-containing medicines and administration of spironolactone together with intravenous and oral potassium supplement, her serum potassium level was normalized and her clinical symptoms and hypertension improved within 2 weeks." | 3.74 | Severe hypokalemia, rhabdomyolysis, muscle paralysis, and respiratory impairment in a hypertensive patient taking herbal medicines containing licorice. ( Harada, E; Itoh, T; Mizuno, Y; Yasue, H, 2007) |
"The Epleronone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) trial demonstrated that selective aldosterone blockade with eplerenone significantly reduced total mortality by 15%, combined cardiovascular (CV) mortality/CV hospitalization by 13%, CV mortality by 17% and sudden cardiac death by 21%, vs." | 3.74 | Eplerenone improves prognosis in postmyocardial infarction diabetic patients with heart failure: results from EPHESUS. ( Abuissa, H; O'Keefe, JH; Pitt, B, 2008) |
" The lack of therapeutic response to spironolactone, with a good response to amiloride and recurrence of hypertension and metabolic alkalosis after amiloride cessation that was subsequently treated with amiloride, established the diagnosis of Liddle syndrome." | 3.71 | Liddle syndrome in a newborn infant. ( Assadi, FK; Kimura, RE; Patel, S; Subramanian, U, 2002) |
" She was diagnosed to have Gitelman's syndrome with chondrocalcinosis, which were effectively treated with spironolactone and magnesium supplementation." | 3.70 | A case of Gitelman's syndrome with chondrocalcinosis. ( Hashimoto, K; Hisakawa, N; Itoh, H; Jinnouchi, C; Nishiya, K; Takao, T; Yasuoka, N, 1998) |
"Six adult patients (4 females and 2 males, age range 26-57 years) with Gitelman's syndrome (GS) were treated with spironolactone 200-300 mg/day (n = 5) and/or amiloride 10-30 mg/day (n = 3) for 1-18 months." | 3.69 | Correction of hypokalemia with antialdosterone therapy in Gitelman's syndrome. ( Colussi, G; De Ferrari, ME; Macaluso, M; Minetti, L; Rombolà, G, 1994) |
"A case of primary aldosteronism treated with spironolactone therapy has been followed up for 24 years." | 3.68 | Twenty-four year spironolactone therapy in an aged patient with aldosterone-producing adenoma. ( Hashimoto, T; Ito, Y; Koshida, H; Miyamori, I; Morimoto, S; Morise, T; Takeda, R; Yamazaki, T, 1992) |
" Hypertension, hypokalaemia, hyperaldosteronism and renin suppression were corrected by unilateral adrenalectomy in 3/5 patients and by spironolactone treatment in 2/5." | 3.67 | Primary aldosteronism is comprised of primary adrenal hyperplasia and adenoma. ( Arteaga, EE; Biglieri, EG; Kater, CE, 1984) |
"Acute reversible renal failure with hyperkalemia developed in a 42-year-old woman during treatment of heart failure and hypertension with high doses of enalapril and diuretics." | 3.67 | [Acute reversible kidney insufficiency due to enalapril during diuretic-treated heart insufficiency]. ( Degenhardt, S, 1987) |
" In six patients with Bartter's syndrome, four with pseudo-Bartter's syndrome, and twenty with essential hypertension (EH) chronically treated with chlorthalidone, serum potassium (serum K+) and extracellular fluid volume (ECFV) were decreased, while plasma volume (PV) and blood volume (BV) were normal (see Table 1 for means, standard deviations, and levels of significance)." | 3.67 | Blood to interstitial fluid volume ratio in chronic hypokalaemic states. ( Boer, P; Dorhout Mees, EJ; Geyskes, GG; Hené, RJ; Koomans, HA; Roos, JC; Van Shaik, BA, 1985) |
"In 8 out of 20 patients with chronic liver disease ascites was controlled with metolazone, 10 required additional amiloride or spironolactone to achieve control, and 2 were resistant to all diuretic therapy." | 3.65 | Use of metolazone in the treatment of ascites due to liver disease. ( Hillenbrand, P; Sherlock, S, 1971) |
"During treatment with indomethacin in a patient with Bartter's syndrome, hypokalemia, high plasma renin concentration, hyperaldosteronism and decreased sensitivity to angiotensin infusion were corrected." | 3.65 | Bartter's syndrome with hyperplasia of renomedullary cells: successful treatment with indomethacin. ( Amery, A; Clement, J; Michielsen, P; van Damme B, B; Verberckmoes, R, 1976) |
"Triamterene therapy was evaluated in 35 patients with congestive heart failure over a period of two and one-half years." | 3.64 | CLINICAL EXPERIENCE WITH A NEW DIURETIC, TRIAMTERENE, IN CONJESTIVE HEART FAILURE. ( LAUFER, ST; MAHABIR, RN, 1964) |
"Indomethacin was the most effective but can cause gastrointestinal intolerance and decreased eGFR." | 2.80 | Indomethacin, amiloride, or eplerenone for treating hypokalemia in Gitelman syndrome. ( Allard, J; Azizi, M; Baron, S; Bergerot, D; Blanchard, A; Bridoux, F; Caumont-Prim, A; Desport, E; Dubourg, L; Essig, M; Monge, M; Tack, I; Vallet, M; Vargas-Poussou, R, 2015) |
"Acquired Gitelman syndrome is a very rare disorder reported in association with autoimmune disorders, mostly Sjögren syndrome." | 2.72 | Hypokalaemic paralysis and metabolic alkalosis in a patient with Sjögren syndrome: a case report and literature review. ( Gunapala, A; Perera, S; Ranaweerage, R, 2021) |
" 2 Spironolactone and triamterene had significant and parallel dose-response curves for plasma potassium, with a relative potency for triamterene:spironolactone of 0." | 2.65 | Relative potency of spironolactone, triamterene and potassium chloride in thiazide-induced hypokalaemia. ( Jackson, PR; Ramsay, LE; Wakefield, V, 1982) |
"Primary aldosteronism with a prevalence of 8 % of hypertension and 20 % of pharmacologically resistant hypertension is the most common secondary cause of hypertension." | 2.53 | Diagnosing and Managing Primary Aldosteronism in Hypertensive Patients: a Case-Based Approach. ( Carey, RM, 2016) |
"The identification of primary aldosteronism as a common cause of resistant hypertension is a significant advance in our ability to care for patients with hypertension." | 2.49 | Endocrine and hypertensive disorders of potassium regulation: primary aldosteronism. ( Weiner, ID, 2013) |
"Primary hyperaldosteronism (PHA) is characterized by an increased Aldosterone synthesis which is independent of the Renin-Angiotensin-Aldosterone-System (RAAS)." | 2.48 | [Primay hyperaldosteronism--diagnostic and treatment]. ( Beuschlein, F; Potthoff, SA; Vonend, O, 2012) |
"Primary hyperaldosteronism will be the most common etiology." | 2.47 | [Primary hyperaldosteronism]. ( Chambaz, IC; Pechère-Bertschi, A, 2011) |
"Primary hyperaldosteronism is characterised by hypertension, hypokalemia, suppressed plasma renin activity, and increased aldosterone excretion." | 2.45 | Rhabdomyolysis due to primary hyperaldosteronism. ( Corrales, PP; López, AH; Martínez, JJ; Meneses, AL; Oliveira, CL; Rodríguez, SA; Romero, FB, 2009) |
"Eplerenone has the advantage, compared with spironolactone, to be better tolerated in terms of "hormonal" adverse effects." | 2.43 | [The revived interest in aldosterone antagonists]. ( Waeber, B, 2006) |
"Primary aldosteronism (PA) has been regarded for a long time as being a rare cause of arterial hypertension, but its prevalence has recently been reassessed as about 10%." | 2.42 | [Investigation of hyperaldosteronism in the hypertensive patient. Why? When? How?]. ( Amar, J; Chamontin, B; Herpin, D; Sosner, P, 2003) |
"For the first time neonatal variant of Bartter syndrome to 14." | 2.42 | [Bartter syndrome and it's neonatal type]. ( Jakutovic, M; Jankauskiene, A, 2003) |
"The renal sodium retention in congestive heart failure is a consequence of the activation of the sympathetic nervous system and of the renin-angiotensin-aldosterone system." | 2.41 | [Diuretic therapy in congestive heart failure--new views on spironolactone therapy]. ( Haller, C, 2000) |
"Gitelman's syndrome is characterised by hypokalaemia, hypomagnesaemia and tetany." | 2.40 | An incidental finding of Gitelman's syndrome. ( Leonard, MB; Neithercut, D, 1997) |
" Suitable techniques for the investigation of secondary aldosteronism of unknown cause and for primary and secondary hypoaldosteronism are described, as well as the adjustment of dosage for replacement therapy where mineralocorticoid secretion is deficient." | 2.37 | Disorders of mineralocorticoid activity. ( Drury, PL, 1985) |
"Spironolactone was initiated." | 1.72 | Apparent mineralocorticoid excess: A diagnosis beyond classical causes of severe hypertension in a child. ( Baltu, D; Çelik Ertaş, NB; Duzova, A; Gönç, N; Gulhan, B; Ozcan, HN; Özdemir, G; Ünsal, Y; Utine, E, 2022) |
"In conclusion, hypokalemia is extremely common in patients presenting with VT/VF, much more so than in patients with CHF alone." | 1.56 | Electrolyte Abnormalities in Patients Presenting With Ventricular Arrhythmia (from the LYTE-VT Study). ( Basil, A; Cooper, JM; Gangireddy, C; Greenberg, RM; Laslett, DB; Whitman, IR; Yesenosky, GA, 2020) |
"These features were consistent with the Gitelman syndrome." | 1.56 | Systemic lupus erythematosus complicated by a Gitelman-like syndrome in an 8-year-old girl. ( Barathidasan, GS; Dhandapany, G; Ganesh, RN; Karunakar, P; Krishnamurthy, S; Rajendran, R; Ramamoorthy, JG; Ramya, K, 2020) |
"Treatment of primary aldosteronism (PA) aims at preventing or correcting hypertension, hypokalemia and target organ damage." | 1.43 | SFE/SFHTA/AFCE consensus on primary aldosteronism, part 6: Adrenal surgery. ( Amar, L; Chaffanjon, P; Kraimps, JL; Ménégaux, F; Steichen, O; Zinzindohoue, F, 2016) |
"Eplerenone treatment of patients with PA reduces blood pressure, increases serum potassium level, and improves vascular status." | 1.43 | Eplerenone improves carotid intima-media thickness (IMT) in patients with primary aldosteronism. ( Anzai, K; Kawate, H; Matsuda, Y; Matsuzaki, C; Nomura, M; Ohnaka, K; Sakamoto, R; Shibue, K; Takayanagi, R, 2016) |
"Inherited classic Bartter syndrome (cBS) is an autosomal recessive renal tubular disorder resulting from inactivating mutations in the asolateral chloride channel (C1C-Kb) and usually presents in early infancy or childhood with mild to moderate hypokalemia." | 1.40 | Hypokalemic paralysis in a middle-aged female with classic Bartter syndrome. ( Chan, JS; Chiang, WF; Lin, SH, 2014) |
"These findings were compatible with Gitelman's syndrome (GS)." | 1.38 | Eplerenone improved hypokalemia in a patient with Gitelman's syndrome. ( Ito, Y; Maeda, H; Miyata, M; Nakayama, M; Ogawa, K; Oiso, Y; Tsutaya, S; Yoshida, M, 2012) |
"We report a case of Gitelman syndrome presenting with fatigue, paresthesias, weakness of limbs and neck muscles since 2." | 1.38 | Gitelman syndrome: novel mutation and long-term follow-up. ( Bagga, A; Basu, B; Gulati, A; Hari, P; Lněnička, P; Sinha, A, 2012) |
"A diagnosis of Gitelman syndrome was made." | 1.37 | Quadriparesis in an adult--Gitelman syndrome. ( Ahmed, S; Farooq, F; Qayyum, M, 2011) |
"Rhabdomyolysis is a rare presentation of hypokalemia, although muscle weakness is a well known manifestation of marked hypokalemia." | 1.35 | An unusual case of an aldosterone-producing adrenocortical adenoma presenting with rhabdomyolysis. ( Ahmetoğlu, A; Bahat, E; Imamoğlu, M; Karagüzel, G; Okten, A; Yildiz, K, 2009) |
"Treatment of primary aldosteronism decreased blood pressure (BP) and restored normal potassium concentrations." | 1.34 | Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment. ( Baroselli, S; Bazzocchi, M; Catena, C; Chiuch, A; Colussi, GL; Lapenna, R; Nadalini, E; Novello, M; Sechi, LA, 2007) |
" Patient demographic information was collected, as well as dosing regimens, use of other medications, and potassium concentrations." | 1.33 | Clinical experience with spironolactone in pediatrics. ( Buck, ML, 2005) |
"We present a patient with Type 2 diabetes and previously undiagnosed hyperaldosteronism who developed life-threatening hypokalaemia while following a low-carbohydrate diet." | 1.33 | Life-threatening hypokalaemia on a low-carbohydrate diet associated with previously undiagnosed primary hyperaldosteronism [corrected]. ( Advani, A; Taylor, R, 2005) |
"We report a rare case of adrenocortical carcinoma." | 1.32 | Co-secretion of aldosterone and cortisol by an adrenocortical carcinoma. ( Azizlerli, H; Kapran, Y; Kurtulmus, N; Yarman, S, 2004) |
"Liddle's syndrome is a rare form of autosomal-dominant salt-sensitive hypertension." | 1.31 | A family with liddle's syndrome caused by a mutation in the beta subunit of the epithelial sodium channel. ( Kitamura, K; Kyuma, M; Sasaki, S; Shimamoto, K; Takeuchi, H; Takizawa, H; Tomita, K; Torii, T; Ura, N, 2001) |
"Primary aldosteronism is a common cause of non-renal secondary hypertension." | 1.31 | Normokalemic hyperaldosteronism in patients with resistant hypertension. ( Benchetrit, S; Bernheim, J; Podjarny, E, 2002) |
"Primary hyperaldosteronism was detected in 1% of patients evaluated for secondary hypertension in a referral hospital in Southern India." | 1.29 | Primary hyperaldosteronism--diagnostic approach and management. ( Cherian, AM; Jesudason, SR; Kanagasabapathy, AS; Nair, A; Seshadri, MS, 1993) |
"Treatment with spironolactone alone, or in combination with either intravenous dopamine or ibopamine orally, amiloride, enalapril, hydralazine or clonidine corrected serum potassium values but failed to normalize blood pressure and to correct plasma renin activity and plasma aldosterone." | 1.28 | A neonate with idiopathic hyperaldosteronism. ( Derkx, FH; Donckerwolcke, RA; Griffiven, AW; Schalekamp, MA; Vande Walle, JG; Veenhoven, RH; Wit, JM, 1991) |
"On the other hand, hypopotassemia (2." | 1.28 | [A case of pseudohypoparathyroidism (PHP) type II associated with Bartter's syndrome--restoration of phosphaturic response to parathyroid hormone (PTH) by treatment for hypopotassemia]. ( Bando, Y; Kobayashi, K; Miyakoshi, H; Nagaoka, T; Ohsawa, K, 1992) |
"In other words, the Bartter's syndrome or the hypopotassemia should be one of the fundamental disorders for developing tetanic symptom." | 1.27 | [Development of tetany in siblings suffered from Bartter's syndrome]. ( Kimura, S; Kita, S; Okamoto, S; Shiozaki, Y; Suitsu, N, 1984) |
"Treatment with spironolactone alone for 2 months corrected hypertension, hypokalemic alkalosis, and all laboratory and radiologic evidence of rickets and hyperparathyroidism, resulting in acceleration of growth rate." | 1.27 | Spironolactone-reversible rickets associated with 11 beta-hydroxysteroid dehydrogenase deficiency syndrome. ( Arnhold, IJ; Batista, MC; Bloise, W; Kater, CE; Mendonça, BB; Nicolau, W; Rocha, A, 1986) |
"The magnesium deficiency is especially dangerous since it prevents the cells from keeping their high intracellular potassium concentration unchanged." | 1.27 | Potassium-sparing diuretics. ( Dyckner, T; Wester, PO, 1986) |
"Additional evidence suggests that sudden death may occasionally result from this VEA." | 1.27 | Potassium loss, ventricular irritability, and the risk of sudden death in hypertensive patients. ( Holland, OB, 1986) |
"The complications to renal tubular acidosis such as hypokalemic muscle paralysis or chronic muscle weakness, nephrolithiasis, and osteomalacia can be avoided if the diagnosis of renal tubular acidosis is made and corrective alkali therapy is maintained." | 1.27 | Hypokalemic paralysis in Sjögren's syndrome secondary to renal tubular acidosis. ( Christensen, KS, 1985) |
"Thus, the present case of pseudoaldosteronism was attributed to Jintan, and raises a caution to excessive Jintan ingestion." | 1.26 | A case of pseudoaldosteronism due to addiction of Jintan, a mouth refresher popular among Japanese. ( Arakawa, K; Kamei, H, 1982) |
"Amiloride was disproportionately potent in lowering serum bicarbonate, and the data do not suggest that these drugs elevate plasma potassium simply by correcting metabolic alkalosis." | 1.26 | Amiloride, spironolactone, and potassium chloride in thiazide-treated hypertensive patients. ( Fraser, R; Hettiarachchi, J; Morton, JJ; Ramsay, LE, 1980) |
"In an 18-year-old boy with Bartter's syndrome, hypophosphatemia was discovered (2." | 1.26 | Hypophosphatemia and hyperparathyroidism in a case of Bartter's syndrome. ( Bernheim, J; David, L; François, R; Sann, L, 1978) |
"A 63-year-old man had asymptomatic Bartter's syndrome, discovered during evaluation for hypokalemia." | 1.26 | Asymptomatic Bartter's syndrome. ( Barbour, GL; Day, JO, 1978) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 165 (66.00) | 18.7374 |
1990's | 16 (6.40) | 18.2507 |
2000's | 32 (12.80) | 29.6817 |
2010's | 32 (12.80) | 24.3611 |
2020's | 5 (2.00) | 2.80 |
Authors | Studies |
---|---|
Gulhan, B | 1 |
Ünsal, Y | 1 |
Baltu, D | 1 |
Çelik Ertaş, NB | 1 |
Özdemir, G | 1 |
Utine, E | 1 |
Ozcan, HN | 1 |
Duzova, A | 1 |
Gönç, N | 1 |
Kucuk, N | 1 |
Yavas Abalı, Z | 1 |
Abalı, S | 1 |
Canpolat, N | 1 |
Yesil, G | 1 |
Turan, S | 1 |
Bereket, A | 1 |
Guran, T | 1 |
Barathidasan, GS | 1 |
Krishnamurthy, S | 1 |
Karunakar, P | 1 |
Rajendran, R | 1 |
Ramya, K | 1 |
Dhandapany, G | 1 |
Ramamoorthy, JG | 1 |
Ganesh, RN | 1 |
Laslett, DB | 1 |
Cooper, JM | 1 |
Greenberg, RM | 1 |
Yesenosky, GA | 1 |
Basil, A | 1 |
Gangireddy, C | 1 |
Whitman, IR | 1 |
Ranaweerage, R | 1 |
Perera, S | 1 |
Gunapala, A | 1 |
Moffett, BS | 1 |
Haworth, TE | 1 |
Wang, Y | 1 |
Afonso, N | 1 |
Checchia, PA | 1 |
Langote, A | 1 |
Hiremath, S | 1 |
Ruzicka, M | 1 |
McCormick, BB | 1 |
Buhl, LF | 1 |
Pedersen, FN | 1 |
Andersen, MS | 1 |
Glintborg, D | 1 |
Beldhuis, IE | 1 |
Myhre, PL | 1 |
Claggett, B | 4 |
Damman, K | 1 |
Fang, JC | 1 |
Lewis, EF | 1 |
O'Meara, E | 1 |
Pitt, B | 5 |
Shah, SJ | 1 |
Voors, AA | 1 |
Pfeffer, MA | 1 |
Solomon, SD | 4 |
Desai, AS | 3 |
Naito, T | 1 |
Hagiya, H | 1 |
Nakagami, F | 1 |
Yamamoto, K | 1 |
Vardeny, O | 3 |
Cavallari, LH | 1 |
Anand, I | 2 |
Rossignol, P | 3 |
Zannad, F | 3 |
Weiner, ID | 1 |
Petramala, L | 1 |
Savoriti, C | 1 |
Zinnamosca, L | 1 |
Marinelli, C | 1 |
Settevendemmie, A | 1 |
Calvieri, C | 1 |
Catani, M | 1 |
Letizia, C | 1 |
Blanchard, A | 1 |
Vargas-Poussou, R | 1 |
Vallet, M | 1 |
Caumont-Prim, A | 1 |
Allard, J | 1 |
Desport, E | 1 |
Dubourg, L | 1 |
Monge, M | 1 |
Bergerot, D | 1 |
Baron, S | 1 |
Essig, M | 1 |
Bridoux, F | 1 |
Tack, I | 1 |
Azizi, M | 1 |
Yongsiri, S | 1 |
Thammakumpee, J | 1 |
Prongnamchai, S | 1 |
Tengpraettanakorn, P | 1 |
Chueansuwan, R | 1 |
Tangjaturonrasme, S | 1 |
Dinchuthai, P | 1 |
Matsuda, Y | 1 |
Kawate, H | 1 |
Matsuzaki, C | 1 |
Sakamoto, R | 2 |
Shibue, K | 1 |
Ohnaka, K | 1 |
Anzai, K | 1 |
Nomura, M | 2 |
Takayanagi, R | 1 |
Schaefer, JA | 1 |
Gales, MA | 1 |
Steichen, O | 2 |
Amar, L | 2 |
Chaffanjon, P | 2 |
Kraimps, JL | 2 |
Ménégaux, F | 2 |
Zinzindohoue, F | 2 |
Baguet, JP | 1 |
Bardet, S | 1 |
Chamontin, B | 2 |
Douillard, C | 1 |
Durieux, P | 1 |
Girerd, X | 1 |
Gosse, P | 1 |
Hernigou, A | 1 |
Herpin, D | 3 |
Houillier, P | 1 |
Jeunemaitre, X | 1 |
Joffre, F | 1 |
Lefebvre, H | 2 |
Mounier-Véhier, C | 1 |
Nussberger, J | 1 |
Pagny, JY | 1 |
Pechère, A | 1 |
Plouin, PF | 2 |
Reznik, Y | 1 |
Tabarin, A | 1 |
Zennaro, MC | 1 |
Chabre, O | 1 |
Pechère-Bertschi, A | 2 |
Kaplan, NM | 3 |
Liu, T | 1 |
Wang, C | 1 |
Lu, J | 1 |
Zhao, X | 1 |
Lang, Y | 1 |
Shao, L | 1 |
Carey, RM | 1 |
Girerd, N | 1 |
Bakris, G | 1 |
McMurray, JJV | 1 |
Swedberg, K | 1 |
Krum, H | 1 |
van Veldhuisen, DJ | 1 |
Shi, H | 1 |
Spanyers, S | 1 |
Vincent, J | 1 |
Fay, R | 1 |
Lamiral, Z | 1 |
Kagan, MD | 1 |
Schmidt, K | 1 |
Sangha, G | 1 |
Kinoshita, H | 1 |
Okabayashi, M | 1 |
Kaneko, M | 1 |
Yasuda, M | 1 |
Abe, K | 1 |
Machida, A | 1 |
Ohkubo, T | 1 |
Kamata, T | 1 |
Yakushiji, F | 1 |
Martínez, JJ | 1 |
Oliveira, CL | 1 |
Meneses, AL | 1 |
Rodríguez, SA | 1 |
Corrales, PP | 1 |
López, AH | 1 |
Romero, FB | 1 |
Karagüzel, G | 1 |
Bahat, E | 1 |
Imamoğlu, M | 1 |
Ahmetoğlu, A | 1 |
Yildiz, K | 1 |
Okten, A | 1 |
Harada, E | 2 |
Yasue, H | 2 |
Mizuno, Y | 2 |
Morikawa, Y | 1 |
Nakagawa, H | 1 |
Semba, F | 1 |
Yoshimura, M | 1 |
Saito, Y | 1 |
Sundar, U | 1 |
Lakkas, Y | 1 |
Asole, D | 1 |
Vaidya, M | 1 |
Abrishamkar, S | 1 |
Shafiei, M | 2 |
Ahmed, S | 1 |
Qayyum, M | 1 |
Farooq, F | 1 |
Chambaz, IC | 1 |
Sinha, A | 1 |
Lněnička, P | 1 |
Basu, B | 1 |
Gulati, A | 1 |
Hari, P | 1 |
Bagga, A | 1 |
Ito, Y | 2 |
Yoshida, M | 2 |
Nakayama, M | 1 |
Tsutaya, S | 1 |
Ogawa, K | 1 |
Maeda, H | 1 |
Miyata, M | 1 |
Oiso, Y | 2 |
Park, PG | 1 |
Karet Frankl, FE | 1 |
Chiang, WF | 1 |
Lin, SH | 2 |
Chan, JS | 1 |
Potthoff, SA | 1 |
Beuschlein, F | 1 |
Vonend, O | 1 |
Al-Harbi, T | 1 |
Al-Shaikh, A | 1 |
Assadi, FK | 1 |
Kimura, RE | 1 |
Subramanian, U | 1 |
Patel, S | 1 |
Demirer, T | 1 |
Ayli, M | 1 |
Dagli, M | 1 |
Fen, T | 1 |
Haznedar, R | 1 |
Ustael, N | 1 |
Ustun, T | 1 |
Oymak, A | 1 |
Ozdel, O | 1 |
Muftuoglu, O | 1 |
Sosner, P | 1 |
Amar, J | 1 |
Jankauskiene, A | 1 |
Jakutovic, M | 1 |
Coca, SG | 1 |
Buller, GK | 1 |
NAPIORKOWSKA, W | 1 |
ZIELINSKI, J | 1 |
NEUMAYR, A | 1 |
THUMB, N | 1 |
TRETENHAHN, W | 1 |
OLESEN, K | 1 |
SANDOE, E | 1 |
FORLAND, M | 1 |
PULLMAN, TN | 1 |
GOLDBERG, M | 1 |
MCCURDY, DK | 1 |
ELMAHALLAWI, MN | 1 |
SAYED, WA | 1 |
EZZAT, E | 1 |
KUECHEL, O | 1 |
HORKY, K | 1 |
JIRANKOVA, J | 1 |
KAPITOLA, J | 1 |
CONTE, M | 2 |
FOUET, P | 1 |
JACOBS, C | 1 |
BROWN, JJ | 4 |
DAVIES, DL | 1 |
LEVER, AF | 4 |
ROBERTSON, JI | 4 |
CRANE, MG | 2 |
ANDES, JP | 1 |
HARRIS, JJ | 2 |
SLATE, WG | 1 |
BAGROS, P | 1 |
ROYER, P | 1 |
DELAITRE, R | 1 |
MATHIEU, H | 1 |
GABILAN, JC | 1 |
RAYNAUD, C | 1 |
PASQUALINI, JR | 1 |
DEBRIS, P | 1 |
GERBEAUX, S | 1 |
HABIB, R | 1 |
CAVELL, B | 1 |
HOEKFELT, B | 1 |
LAUFER, ST | 1 |
MAHABIR, RN | 1 |
STOKES, W | 1 |
PEARSON, CM | 1 |
BLAGG, CR | 1 |
GLANVILLE, JN | 1 |
MAHER, JF | 1 |
SCHREINER, GE | 1 |
CHRISTIANSEN, J | 1 |
HAGERUP, L | 1 |
NIELSEN, B | 1 |
DE GRAEFF, J | 1 |
LAMEIJER, LD | 1 |
GEOKAS, MC | 1 |
CHUN, JY | 1 |
DINAN, JJ | 1 |
BECK, IT | 1 |
HERBER, R | 1 |
DUPASQUIER, E | 1 |
BOUCHER, BJ | 1 |
MASON, AS | 1 |
Monnens, L | 1 |
Levtchenko, E | 1 |
Cachat, F | 1 |
Guignard, JP | 1 |
Kurtulmus, N | 1 |
Yarman, S | 1 |
Azizlerli, H | 1 |
Kapran, Y | 1 |
Talib, A | 1 |
Mahmood, K | 1 |
Jairamani, KL | 1 |
Samo, A | 1 |
Shakoor, A | 1 |
Ghanghro, I | 1 |
Mehar, S | 1 |
Kim, JB | 1 |
Lee, KY | 1 |
Hur, JK | 1 |
Buck, ML | 1 |
Khurshid, KA | 1 |
Weaver, ME | 1 |
Freedman, DB | 1 |
Housley, D | 1 |
Advani, A | 1 |
Taylor, R | 1 |
Suzuki, A | 1 |
Miura, Y | 1 |
Waeber, B | 1 |
Koga, Y | 1 |
Ohe, K | 1 |
Gondo, S | 1 |
Watanabe, T | 1 |
Okabe, T | 1 |
Kawazoe, N | 1 |
Sasano, K | 1 |
Yanase, T | 1 |
Itoh, T | 1 |
O'Keefe, JH | 1 |
Abuissa, H | 1 |
Novello, M | 1 |
Catena, C | 1 |
Nadalini, E | 1 |
Colussi, GL | 1 |
Baroselli, S | 1 |
Chiuch, A | 1 |
Lapenna, R | 1 |
Bazzocchi, M | 1 |
Sechi, LA | 1 |
Carmona-Bayonas, A | 1 |
Soler, IO | 1 |
Gómez, FI | 1 |
Billalabeitia, EG | 1 |
Saura, HP | 1 |
Tafalla, MS | 1 |
Díaz, MP | 1 |
Karagiannis, A | 1 |
Tziomalos, K | 1 |
Papageorgiou, A | 1 |
Kakafika, AI | 1 |
Pagourelias, ED | 1 |
Anagnostis, P | 1 |
Athyros, VG | 1 |
Mikhailidis, DP | 1 |
Hoff, F | 1 |
Seller, RH | 1 |
Ramirez, O | 1 |
Brest, AN | 1 |
Davis, WW | 1 |
Newsome, HH | 1 |
Wright, LD | 1 |
Hammond, WG | 1 |
Easton, J | 1 |
Bartter, FC | 1 |
Gwinup, G | 1 |
Steinberg, T | 1 |
Harinck, HI | 1 |
van Brummelen, P | 1 |
Van Seters, AP | 1 |
Moolenaar, AJ | 1 |
Greathouse, DJ | 1 |
McDermott, MT | 1 |
Kidd, GS | 1 |
Hofeldt, FD | 1 |
Muratani, H | 1 |
Kawasaki, T | 1 |
Omae, T | 1 |
Suitsu, N | 1 |
Kita, S | 1 |
Okamoto, S | 1 |
Kimura, S | 1 |
Shiozaki, Y | 1 |
Biglieri, EG | 1 |
Kater, CE | 2 |
Arteaga, EE | 1 |
Kijima, Y | 1 |
Sasaoka, T | 1 |
Kamei, H | 1 |
Arakawa, K | 1 |
Jackson, PR | 1 |
Ramsay, LE | 3 |
Wakefield, V | 1 |
Lawson, DH | 1 |
O'Connor, PC | 1 |
Jick, H | 1 |
Holzgreve, H | 1 |
Haalboom, JR | 1 |
Struyvenberg, A | 2 |
Kallen, RJ | 1 |
Aronson, DJ | 1 |
Hettiarachchi, J | 2 |
Koate, P | 1 |
Diouf, S | 1 |
Sylla, M | 1 |
Diop, G | 1 |
Diop, SN | 1 |
de Jong, PE | 1 |
Donker, AJ | 1 |
van der Wall, E | 1 |
Erkelens, DW | 1 |
van der Hem, GK | 1 |
Doorenbos, H | 1 |
Fraser, R | 4 |
Morton, JJ | 1 |
Gross, DJ | 1 |
Ben Chetrit, E | 1 |
Stein, P | 1 |
Rosler, A | 1 |
Eliakim, M | 1 |
Colussi, G | 1 |
Rombolà, G | 1 |
De Ferrari, ME | 1 |
Macaluso, M | 1 |
Minetti, L | 1 |
Seshadri, MS | 1 |
Kanagasabapathy, AS | 1 |
Cherian, AM | 1 |
Nair, A | 1 |
Jesudason, SR | 1 |
Bień, B | 1 |
Lamnari, AM | 1 |
Górska, M | 1 |
Haris, A | 1 |
Radó, J | 1 |
Leonard, MB | 1 |
Neithercut, D | 1 |
Hisakawa, N | 1 |
Yasuoka, N | 1 |
Itoh, H | 1 |
Takao, T | 1 |
Jinnouchi, C | 1 |
Nishiya, K | 1 |
Hashimoto, K | 1 |
Rosen, CA | 1 |
Thomas, JP | 1 |
Anderson, D | 1 |
Haller, C | 1 |
Ural, AU | 2 |
Laragh, JH | 1 |
Sealey, JE | 1 |
Kyuma, M | 1 |
Ura, N | 1 |
Torii, T | 1 |
Takeuchi, H | 1 |
Takizawa, H | 1 |
Kitamura, K | 1 |
Tomita, K | 1 |
Sasaki, S | 1 |
Shimamoto, K | 1 |
Massien-Simon, C | 1 |
Benchetrit, S | 1 |
Bernheim, J | 2 |
Podjarny, E | 1 |
Shargorodsky, M | 1 |
Zimlichman, R | 1 |
Avcu, F | 1 |
Cetin, T | 1 |
Beyan, C | 1 |
Kaptan, K | 1 |
Nazaroglu, NK | 1 |
Yalcin, A | 1 |
Wilkins, GE | 1 |
McGuffin, WL | 1 |
Gunnells, JC | 2 |
Kohvakka, A | 1 |
Eisalo, A | 1 |
Manninen, V | 1 |
Roeltgen, D | 1 |
Marone, C | 1 |
Beretta-Piccoli, C | 1 |
Weidmann, P | 1 |
Wortsman, J | 1 |
Soler, NG | 1 |
Wilkinson, PR | 1 |
López, JM | 1 |
Rodríguez, JA | 1 |
Rosenberg, H | 1 |
Atria, P | 1 |
Adu, D | 1 |
Nkrumah, KN | 1 |
Larbi, EB | 1 |
Pobee, JO | 1 |
Adjei, DO | 1 |
Cannon, ML | 1 |
Tannenbaum, RP | 1 |
La Franco, M | 1 |
Sann, L | 1 |
David, L | 1 |
François, R | 1 |
Barbour, GL | 1 |
Day, JO | 1 |
Préda, I | 1 |
Sebeszta, M | 1 |
Harsányi, A | 1 |
Szabó, G | 1 |
Antalóczy, Z | 1 |
Ohmae, M | 1 |
Nohara, Y | 1 |
Takayasu, M | 1 |
Saimyoji, H | 1 |
Seriu, Y | 1 |
Verberckmoes, R | 1 |
van Damme B, B | 1 |
Clement, J | 1 |
Amery, A | 1 |
Michielsen, P | 1 |
Gifford, RW | 1 |
Rose, JC | 1 |
Rowe, WS | 1 |
Ono, F | 1 |
Harada, H | 1 |
Komatsu, K | 1 |
Saijo, K | 1 |
Miyoshi, K | 1 |
Schwartz, AB | 1 |
Takeda, R | 1 |
Yamazaki, T | 1 |
Koshida, H | 1 |
Morise, T | 1 |
Miyamori, I | 1 |
Hashimoto, T | 1 |
Morimoto, S | 1 |
Bravo Mata, M | 1 |
Alonso Martín, A | 1 |
Fuster Siebert, M | 1 |
Paz Fernández, M | 1 |
Cocho de Juan, J | 1 |
Bando, Y | 1 |
Miyakoshi, H | 1 |
Nagaoka, T | 1 |
Ohsawa, K | 1 |
Kobayashi, K | 1 |
Kanemoto, N | 1 |
Nakayama, K | 1 |
Ide, M | 1 |
Goto, Y | 1 |
Rahman, AR | 1 |
McDevitt, DG | 2 |
Struthers, AD | 2 |
Lipworth, BJ | 2 |
Veenhoven, RH | 1 |
Vande Walle, JG | 1 |
Donckerwolcke, RA | 1 |
Wit, JM | 1 |
Griffiven, AW | 1 |
Derkx, FH | 1 |
Schalekamp, MA | 1 |
Koshikawa, S | 1 |
Shimizu, N | 1 |
DiMartino-Nardi, J | 2 |
Stoner, E | 2 |
Martin, K | 1 |
Balfe, JW | 1 |
Jose, PA | 1 |
New, MI | 3 |
Batista, MC | 1 |
Mendonça, BB | 1 |
Arnhold, IJ | 1 |
Rocha, A | 1 |
Nicolau, W | 1 |
Bloise, W | 1 |
Degenhardt, S | 1 |
Krishna, GG | 1 |
Shulman, MD | 1 |
Narins, RG | 1 |
Tourniaire, J | 1 |
Bajard, L | 1 |
Harfouch, M | 1 |
Rebattu, B | 1 |
Garrel, D | 1 |
Dyckner, T | 1 |
Wester, PO | 1 |
Rorive, G | 1 |
Krzesinski, JM | 1 |
Greenberg, A | 1 |
Holland, OB | 1 |
Lant, A | 1 |
Drury, PL | 1 |
Boer, P | 1 |
Koomans, HA | 1 |
Hené, RJ | 1 |
Geyskes, GG | 1 |
Van Shaik, BA | 1 |
Roos, JC | 1 |
Dorhout Mees, EJ | 1 |
Nekrasova, AA | 1 |
Christensen, KS | 1 |
Stewart, DE | 1 |
Ikram, H | 1 |
Espiner, EA | 1 |
Nicholls, MG | 1 |
Ferriss, JB | 2 |
Kay, AW | 1 |
Neville, AM | 1 |
O'Muircheartaigh, IG | 1 |
Symington, T | 1 |
Love, DR | 1 |
Wilson, A | 1 |
George, CF | 1 |
Breckenridge, AM | 1 |
Dollery, CT | 1 |
Caplan, RH | 1 |
Virata, RL | 1 |
Sherlock, S | 4 |
Senewiratne, B | 3 |
Scott, A | 2 |
Walker, JG | 2 |
Thind, GS | 1 |
Blakemore, WS | 1 |
Zinsser, HF | 1 |
Hänze, S | 1 |
Pierach, CA | 1 |
Stark, G | 1 |
Greenberg, AJ | 1 |
Arboit, JM | 1 |
Worthen, HG | 1 |
Beilin, LJ | 1 |
Schiffman, N | 1 |
Crane, M | 1 |
Nelson, DH | 1 |
Mertens, HG | 1 |
Lurati, M | 1 |
Führ, J | 1 |
Bodin, F | 1 |
Liguory, C | 1 |
Capelle, P | 1 |
Meurer, KA | 1 |
Kaufmann, W | 1 |
Steiner, B | 1 |
Schürholz, J | 1 |
Streicher, E | 1 |
Nieth, H | 1 |
Dürr, F | 1 |
Held, H | 1 |
Allner, R | 1 |
Goodman, AD | 1 |
Vagnucci, AH | 1 |
Hartroft, PM | 1 |
Bodin, G | 1 |
Rival, JM | 1 |
Gillot, F | 1 |
Sutherland, LE | 1 |
Hartroft, P | 1 |
Balis, JU | 1 |
Bailey, JD | 1 |
Lynch, MJ | 1 |
Desmit, EM | 1 |
Cost, WS | 1 |
Arant, BS | 1 |
Brackett, NC | 1 |
Young, RB | 1 |
Still, WJ | 1 |
Vallotton, MB | 1 |
Scholer, D | 1 |
Muller, AF | 2 |
Spark, RF | 1 |
Ramanathan, K | 1 |
Gantt, C | 1 |
Grossman, A | 1 |
Modlinger, RS | 1 |
Nicolis, GL | 1 |
Krakoff, LR | 1 |
Gabrilove, JL | 1 |
Horton, R | 1 |
Nakada, T | 1 |
Momose, G | 1 |
Yoshida, T | 1 |
Tateno, Y | 1 |
Shigematsu, H | 1 |
Streeten, DH | 1 |
Speller, PJ | 1 |
Martin, PL | 1 |
Dallocchio, M | 1 |
Fourcade, JP | 1 |
Clémenty, J | 1 |
Coqueran, J | 1 |
Choussat, A | 1 |
Bricaud, H | 1 |
Dujardin, P | 1 |
Soubiran, P | 1 |
Niccolai, P | 1 |
Audoly, P | 1 |
Daniel, R | 1 |
Kermarec, J | 1 |
Leemhuis, MP | 1 |
Hodler, J | 1 |
Kaplan, NN | 1 |
Mills, IH | 1 |
Schmidt, P | 2 |
Kopsa, H | 1 |
Kronenberg, KH | 1 |
Meyer, D | 1 |
Zazgornik, J | 1 |
Kotzaurek, R | 1 |
Neumann, E | 1 |
Morgan, TO | 1 |
Dehart, HS | 1 |
Bath, NM | 1 |
Glenn, JF | 1 |
Demanet, JC | 1 |
Silverberg, DS | 1 |
Kjellstrand, CM | 1 |
Sánchez, A | 1 |
Ikeda, T | 1 |
Leiter, L | 1 |
Riecker, G | 1 |
Anderton, JL | 1 |
Kincaid-Smith, P | 1 |
Reubi, FC | 1 |
Hilmer, W | 1 |
Meyer, P | 1 |
Milliez, P | 1 |
Gekle, D | 1 |
Wernze, H | 1 |
Langer, KH | 1 |
Hillenbrand, P | 1 |
Lund-Johansen, P | 1 |
Gardere, J | 1 |
Fanconi, A | 1 |
Schachenmann, G | 1 |
Nüssli, R | 1 |
Prader, A | 1 |
Griggs, RC | 2 |
Engel, WK | 2 |
Resnick, JS | 2 |
Holmes, AM | 1 |
Hesling, CM | 1 |
Wilson, TM | 1 |
Rieselbach, RE | 1 |
Nielsen, H | 1 |
Landbo, K | 1 |
Buckalew, VM | 1 |
Gall, G | 1 |
Vaitukaitis, J | 1 |
Haddow, JE | 1 |
Klein, R | 1 |
Marsen, B | 1 |
Dissmann, T | 1 |
Oelkers, W | 1 |
Lohmann, FW | 1 |
Molzahn, M | 1 |
Gotzen, R | 1 |
Rastogi, SP | 1 |
Volans, G | 1 |
Elliott, RW | 1 |
Eccleston, DW | 1 |
Ashcroft, R | 1 |
Webster, D | 1 |
Kerr, DN | 1 |
Shioji, R | 1 |
Rikimaru, S | 1 |
Ito, H | 1 |
Bauer, HJ | 1 |
Moeller, J | 1 |
Muniz, B | 1 |
Guinet, P | 1 |
Mornex, R | 1 |
Revol, A | 1 |
Bertrand, J | 1 |
Veyrat, A | 1 |
Dorsit, G | 1 |
Stam, AC | 1 |
Veyrat, R | 1 |
Grandchamp, A | 1 |
Bierans de Haan, B | 1 |
Zanchetti, A | 1 |
Lampe, W | 1 |
Stefan, H | 1 |
Helge, H | 1 |
Merker, HJ | 1 |
Bachmann, D | 1 |
Gerstein, AR | 1 |
Franklin, SS | 1 |
Kleeman, CR | 1 |
Maxwell, MH | 1 |
Gold, EM | 1 |
Bianchi, G | 1 |
Campolo, L | 1 |
Alè, G | 1 |
Sala, G | 1 |
Andrieu, J | 1 |
Lesueur, G | 1 |
Semmler, H | 1 |
Mittmann, W | 1 |
Jose, A | 1 |
Awamura, M | 1 |
Ross, EJ | 1 |
Gitelman, HJ | 1 |
Graham, JB | 1 |
Welt, LG | 1 |
Stein, L | 1 |
Shapiro, N | 1 |
Stein, D | 1 |
Niall, JF | 1 |
Pak POY, RK | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
68Ga-Pentixafor PET/CT for the Subtyping Diagnosis of Primary Aldosteronism: A Prospective Diagnostic Accuracy Study[NCT05131061] | 100 participants (Actual) | Observational | 2021-11-11 | Completed | |||
A Randomized Open Label Trial of Spironolactone Versus Prednisolone in Corticosteroid-naïve Boys With DMD[NCT03777319] | Phase 1 | 2 participants (Actual) | Interventional | 2018-12-05 | Terminated (stopped due to Inability to recruit participants.) | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
The determination of whether spironolactone has similar efficacy to glucocorticoids in improving muscle strength in steroid naïve DMD patients. This will be determined by measuring the time to complete a 100 meter timed test (100M). (NCT03777319)
Timeframe: 6 months
Intervention | sec (Number) |
---|---|
Spironolactone | -0.6 |
Prednisolone | -5.3 |
Secondary outcome measures will be Dynamometry score, which is a summation of maximum voluntary isometric contraction test values for knee flexion, knee extension, elbow flexion, and elbow extension (NCT03777319)
Timeframe: 6 months
Intervention | kg (Number) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Elbow Flexion (Right)-Baseline | Elbow Flexion (Left)-Baseline | Elbow Extension (Right)-Baseline | Elbow Extension (Left)-Baseline | Knee Flexion (Right)-Baseline | Knee Flexion (Left)-Baseline | Knee Extension (Right)-Baseline | Knee Extension (Left)-Baseline | Elbow Flexion (Right)-Month 6 | Elbow Flexion (Left)-Month 6 | Elbow Extension (Right)-Month 6 | Elbow Extension (Left)-Month 6 | Knee Flexion (Right)-Month 6 | Knee Flexion (Left)-Month 6 | Knee Extension (Right)-Month 6 | Knee Extension (Left)-Month 6 | |
Prednisolone | 3.6 | 4.1 | 5.3 | 4.1 | 3.3 | 3.4 | 4.8 | 5.2 | 2.9 | 3.4 | 4.3 | 3.8 | 4.1 | 3.9 | 6 | 5.1 |
Spironolactone | 0 | 0 | 0 | 0 | 4.1 | 2.8 | 3.8 | 5.9 | 3.1 | 3.5 | 2.4 | 2.5 | 4.3 | 4.1 | 7.2 | 8.3 |
Electrolytes (Sodium, Potassium, Cloride and Carbon dioxide, mmol/L) will be measured on a monthly basis following initiation of either spironolactone or prednisolone. (NCT03777319)
Timeframe: 6 months
Intervention | mmol/L (Number) | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sodium-Baseline | Sodium-Month 1 | Sodium-Month 2 | Sodium-Month 3 | Sodium-Month 4 | Sodium-Month 5 | Sodium-Month 6 | Potassium-Baseline | Potassium-Month 1 | Potassium-Month 2 | Potassium-Month 3 | Potassium-Month 4 | Potassium-Month 5 | Potassium-Month 6 | Chloride-Baseline | Chloride-Month 1 | Chloride-Month 2 | Chloride-Month 3 | Chloride-Month 4 | Chloride-Month 5 | Chloride-Month 6 | CO2-Baseline | CO2-Month 1 | CO2-Month 2 | CO2-Month 3 | CO2-Month 4 | CO2-Month 5 | CO2-Month 6 | |
Prednisolone | 140 | 140 | 139 | 141 | 139 | 139 | 143 | 3.8 | 4 | 4.5 | 3.9 | 4.6 | 4.2 | 3.9 | 105 | 105 | 104 | 105 | 105 | 106 | 105 | 22 | 24 | 24 | 24 | 25 | 26 | 26 |
Spironolactone | 142 | 142 | 141 | 142 | 139 | 139 | 140 | 4.5 | 4.7 | 4.2 | 4.1 | 4.5 | 4.5 | 4.3 | 103 | 109 | 107 | 103 | 103 | 103 | 101 | 29 | 22 | 25 | 27 | 28 | 28 | 26 |
31 reviews available for spironolactone and Hypokalemia
Article | Year |
---|---|
Hypokalaemic paralysis and metabolic alkalosis in a patient with Sjögren syndrome: a case report and literature review.
Topics: Diagnosis, Differential; Dietary Supplements; Gitelman Syndrome; Humans; Hypokalemia; Paralysis; Pot | 2021 |
Endocrine and hypertensive disorders of potassium regulation: primary aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Eplerenone; Humans; Hy | 2013 |
Potassium-Binding Agents to Facilitate Renin-Angiotensin-Aldosterone System Inhibitor Therapy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Chelating Agents; Humans; Hyperkalemia; Hypokalemia; Male; | 2016 |
Diagnosing and Managing Primary Aldosteronism in Hypertensive Patients: a Case-Based Approach.
Topics: Adrenalectomy; Eplerenone; Humans; Hyperaldosteronism; Hypertension; Hypokalemia; Laparoscopy; Mass | 2016 |
Rhabdomyolysis due to primary hyperaldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Female; Humans; Hyperaldosteronism; Hyperten | 2009 |
[Primary hyperaldosteronism].
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenalectomy; Algorithms; Humans; Hyperaldosteronism; Hypertensi | 2011 |
[Primay hyperaldosteronism--diagnostic and treatment].
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenal Hyperplasia, Congenital; Adrenocortical Adenoma; A | 2012 |
[Investigation of hyperaldosteronism in the hypertensive patient. Why? When? How?].
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Age of Onset; Female; Humans; Hyperaldosteronism; Hypertens | 2003 |
[Bartter syndrome and it's neonatal type].
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Bartter Syndrome; Bone Diseases, Metabolic; Cal | 2003 |
[The revived interest in aldosterone antagonists].
Topics: Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Eplerenone; Heart Failure; Human | 2006 |
[Potassium-sparing diuretics (spironolactone, triamterene, amylorid)].
Topics: Amiloride; Diuretics; Humans; Hypertension; Hypokalemia; Potassium Deficiency; Spironolactone; Triam | 1996 |
An incidental finding of Gitelman's syndrome.
Topics: Adult; Calcium; Creatinine; Diuretics; Female; Humans; Hypokalemia; Magnesium; Spironolactone; Syndr | 1997 |
[Diuretic therapy in congestive heart failure--new views on spironolactone therapy].
Topics: Antidiuretic Hormone Receptor Antagonists; Diuretics; Drug Therapy, Combination; Heart Failure; Huma | 2000 |
K(+) depletion and the progression of hypertensive disease or heart failure. The pathogenic role of diuretic-induced aldosterone secretion.
Topics: Aldosterone; Animals; Antihypertensive Agents; Benzothiadiazines; Clinical Trials as Topic; Disease | 2001 |
[Primary hyperaldosteronism].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aged; Aldosterone; Algorithms; Amiloride; Di | 1998 |
Primary aldosteronism.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Aldosterone; Humans; Hyperaldosteronism; | 1977 |
Clinical use of the potassium-sparing diuretics.
Topics: Amiloride; Humans; Hypertension, Renal; Hypokalemia; Potassium; Spironolactone; Triamterene | 1988 |
[Properties and indications of potassium-sparing diuretics].
Topics: Amiloride; Diuretics; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hyperaldosteronism; Hy | 1986 |
Diuretics. Clinical pharmacology and therapeutic use (Part II).
Topics: Amiloride; Canrenoic Acid; Diuretics; Diuretics, Osmotic; Drug Interactions; Hearing Disorders; Hear | 1985 |
Disorders of mineralocorticoid activity.
Topics: 18-Hydroxycorticosterone; Adenoma; Adrenal Glands; Adult; Aldosterone; Angiotensin II; Blood Specime | 1985 |
Aldosterone: review of its physiology and diagnostic aspects of primary aldosteronism.
Topics: Adenoma; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Aldosterone; | 1973 |
Significance of hypokalaemia due to diuretics.
Topics: Amiloride; Arrhythmias, Cardiac; Chlorothiazide; Diuretics; Ethacrynic Acid; Extracellular Space; Fu | 1973 |
[Diagnosis and therapy of primary hyperaldosteronism].
Topics: Adrenal Gland Neoplasms; Aldosterone; Diagnosis, Differential; Female; Humans; Hyperaldosteronism; H | 1972 |
Adrenal causes of hypertension.
Topics: Adenoma; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenocortical Hyperfunction; Adult; Carci | 1974 |
Primary hyperaldosteronism.
Topics: Adrenal Gland Neoplasms; Aldosterone; Corticosterone; Desoxycorticosterone; Electrocardiography; Hum | 1974 |
Commentary on incidence of primary aldosteronism: current estimations based on objective data.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Blood Pressure; Desoxycorticosterone; | 1969 |
[Depletion therapy of chronic congestive heart failure].
Topics: Bloodletting; Carbonic Anhydrase Inhibitors; Chlorides; Diet, Sodium-Restricted; Digitalis Glycoside | 1968 |
[Hypertension--diuretics as antihypertensive agents].
Topics: Aged; Antihypertensive Agents; Arthritis; Benzothiadiazines; Blood Pressure; Chlorothiazide; Chlorth | 1970 |
Combinations of diuretics in the treatment of edema.
Topics: Acetazolamide; Benzothiadiazines; Chlorthalidone; Diuretics; Edema; Ethacrynic Acid; Furosemide; Glu | 1970 |
Diuretics. II. Clinical considerations.
Topics: Administration, Oral; Aminophylline; Ascites; Calcium; Carbohydrate Metabolism; Carbonic Anhydrase I | 1971 |
Combination diuretic drug therapy.
Topics: Amiloride; Benzothiadiazines; Diet; Diuretics; Drug Therapy, Combination; Ethacrynic Acid; Furosemid | 1971 |
23 trials available for spironolactone and Hypokalemia
Article | Year |
---|---|
Race influences the safety and efficacy of spironolactone in severe heart failure.
Topics: Adult; Aged; Biomarkers; Black or African American; Chi-Square Distribution; Double-Blind Method; Fe | 2013 |
Incidence, predictors, and outcomes related to hypo- and hyperkalemia in patients with severe heart failure treated with a mineralocorticoid receptor antagonist.
Topics: Cause of Death; Dose-Response Relationship, Drug; Double-Blind Method; Echocardiography; Follow-Up S | 2014 |
Indomethacin, amiloride, or eplerenone for treating hypokalemia in Gitelman syndrome.
Topics: Adolescent; Adult; Amiloride; Blood Pressure; Body Weight; Cross-Over Studies; Dose-Response Relatio | 2015 |
Randomized, double-blind, placebo-controlled trial of spironolactone for hypokalemia in continuous ambulatory peritoneal dialysis patients.
Topics: Administration, Oral; Adult; Blood Chemical Analysis; Cross-Over Studies; Double-Blind Method; Drug | 2015 |
Impact of eplerenone on cardiovascular outcomes in heart failure patients with hypokalaemia.
Topics: Dose-Response Relationship, Drug; Eplerenone; Europe; Female; Follow-Up Studies; Heart Failure, Syst | 2017 |
Spironolactone in preventing hypokalemia following traumatic brain injury.
Topics: Adult; Brain Injuries; Female; Humans; Hypokalemia; Male; Middle Aged; Spironolactone | 2010 |
The effect of post-transplant spironolactone on daily potassium requirements in patients undergoing autologous stem cell transplantation.
Topics: Adolescent; Adult; Diuretics; Female; Humans; Hypokalemia; Male; Middle Aged; Neoplasms; Peripheral | 2002 |
Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Drug Administratio | 2008 |
Relative potency of spironolactone, triamterene and potassium chloride in thiazide-induced hypokalaemia.
Topics: Adult; Aged; Benzothiadiazines; Blood Pressure; Body Weight; Diuretics; Female; Humans; Hypokalemia; | 1982 |
Spironolactone in thiazide-induced hypokalaemia: variable response between patients.
Topics: Adult; Aldosterone; Benzothiadiazines; Canrenone; Diuretics; Electrolytes; Female; Humans; Hypokalem | 1981 |
Spironolactone: is it a novel drug for the prevention of amphotericin B-related hypokalemia in cancer patients?
Topics: Amphotericin B; Antifungal Agents; Humans; Hypokalemia; Kidney Function Tests; Mineralocorticoid Rec | 2002 |
Maintenance of potassium balance during diuretic therapy.
Topics: Adult; Aged; Amiloride; Clinical Trials as Topic; Drug Combinations; Drug Evaluation; Drug Therapy, | 1979 |
Plasma potassium in hypertensive Africans on frusemide.
Topics: Adult; Aged; Drug Therapy, Combination; Female; Furosemide; Humans; Hypertension; Hypokalemia; Male; | 1978 |
Carbenoxolone sodium for gastric ulcer.
Topics: Benzothiadiazines; Body Weight; Carbenoxolone; Clinical Trials as Topic; Diuretics; Duodenal Ulcer; | 1975 |
The effects of enalapril and spironolactone on terbutaline-induced hypokalemia.
Topics: Adult; Electrocardiography; Enalapril; Female; Hemodynamics; Humans; Hypokalemia; Magnesium; Male; P | 1992 |
Hypokalemic and ECG sequelae of combined beta-agonist/diuretic therapy. Protection by conventional doses of spironolactone but not triamterene.
Topics: Adult; Albuterol; Bendroflumethiazide; Drug Synergism; Drug Therapy, Combination; Electrocardiograph | 1990 |
Comparison of the potassium- retaining effects of amiloride and spironolactone in hypertensive patients with thiazide-induced hypokalaemia.
Topics: Adult; Aged; Amiloride; Blood Pressure; Body Weight; Diuretics; Drug Therapy, Combination; Female; H | 1973 |
Clinical use of high doses of furosemide (Lasix) in the treatment of resistant nephrotic edema.
Topics: Adult; Clinical Trials as Topic; Diabetes Complications; Diuretics; Edema; Female; Furosemide; Glome | 1968 |
Extrarenal effects of diuretic agents.
Topics: Acidosis, Renal Tubular; Adipose Tissue; Alkalosis; Animals; Antihypertensive Agents; Blood Volume; | 1970 |
[Treatment of the hypertensive patient. Value of Amiloride during saldiuretic treatment].
Topics: Adult; Amiloride; Diuretics; Female; Humans; Hydrochlorothiazide; Hypertension; Hypokalemia; Kidney | 1972 |
[Combination therapy with spironolactone and polythiazide in hypertension].
Topics: Blood Pressure; Drug Combinations; Electrolytes; Female; Humans; Hypertension; Hypokalemia; Male; Mi | 1971 |
Acetazolamide treatment of hypokalemic periodic paralysis. Prevention of attacks and improvement of persistent weakness.
Topics: Acetazolamide; Acidosis; Adult; Child; Electrolytes; Female; Humans; Hypokalemia; Male; Middle Aged; | 1970 |
Acetazolamide prophylaxis in hypokalemic periodic paralysis.
Topics: Acetazolamide; Adult; Child; Humans; Hyperkalemia; Hypokalemia; Male; Paralyses, Familial Periodic; | 1968 |
196 other studies available for spironolactone and Hypokalemia
Article | Year |
---|---|
Apparent mineralocorticoid excess: A diagnosis beyond classical causes of severe hypertension in a child.
Topics: Aldosterone; Amiloride; Blood Pressure; Child, Preschool; Female; Humans; Hypertension; Hypokalemia; | 2022 |
A rare cause of hypertension in childhood: Answers.
Topics: Aldosterone; Alkalosis; Bartter Syndrome; Child; Child, Preschool; Consanguinity; Cortisone; Diagnos | 2020 |
Systemic lupus erythematosus complicated by a Gitelman-like syndrome in an 8-year-old girl.
Topics: Alkalosis; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Gitelman Syndrome; Humans; Hy | 2020 |
Electrolyte Abnormalities in Patients Presenting With Ventricular Arrhythmia (from the LYTE-VT Study).
Topics: Aged; Cardiomyopathies; Case-Control Studies; Diarrhea; Diuretics; Female; Heart Failure; Humans; Hy | 2020 |
Spironolactone effect on potassium supplementation in paediatric cardiac intensive care patients.
Topics: Child, Preschool; Cohort Studies; Critical Care; Diuretics; Dose-Response Relationship, Drug; Female | 2017 |
Spironolactone is effective in treating hypokalemia among peritoneal dialysis patients.
Topics: Aged; Blood Pressure; Female; Humans; Hypokalemia; Male; Middle Aged; Peritoneal Dialysis; Retrospec | 2017 |
Licorice-induced apparent mineralocorticoid excess compounded by excessive use of terbutaline and high water intake.
Topics: Aldosterone; Asthma; Bronchodilator Agents; Diagnosis, Differential; Glycyrrhiza; Humans; Hypertensi | 2018 |
Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney Disease.
Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Comorbidity; Deprescriptions; Disease Progression; | 2019 |
An uncommon cause of leg oedema.
Topics: Aged; Aldosterone; Edema; Female; Humans; Hyperaldosteronism; Hypokalemia; Leg; Magnetic Resonance I | 2019 |
Primary aldosteronism with concurrent primary hyperparathyroidism in a patient with arrhythmic disorders.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Arrhythmias, Cardiac; Electr | 2013 |
Eplerenone improves carotid intima-media thickness (IMT) in patients with primary aldosteronism.
Topics: Adrenalectomy; Adult; Aged; Aldosterone; Atherosclerosis; Biomarkers; Carotid Intima-Media Thickness | 2016 |
SFE/SFHTA/AFCE consensus on primary aldosteronism, part 6: Adrenal surgery.
Topics: Adrenalectomy; France; Humans; Hyperaldosteronism; Hypertension; Hypokalemia; Intraoperative Complic | 2016 |
SFE/SFHTA/AFCE primary aldosteronism consensus: Introduction and handbook.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aldosterone; Calcium Channel Blockers; France; Humans | 2016 |
SFE/SFHTA/AFCE consensus on primary aldosteronism, part 7: Medical treatment of primary aldosteronism.
Topics: Eplerenone; Female; France; Humans; Hyperaldosteronism; Hypertension; Hypokalemia; Male; Mineralocor | 2016 |
ARAs to the RESCUE.
Topics: Aldosterone; Eplerenone; Gynecomastia; Humans; Hyperaldosteronism; Hypertension; Hypokalemia; Meta-A | 2016 |
Genotype/Phenotype Analysis in 67 Chinese Patients with Gitelman's Syndrome.
Topics: Adult; Asian People; Calcium; Diabetes Mellitus, Type 2; Diuretics; Female; Genotype; Gitelman Syndr | 2016 |
Indomethacin therapy effective in a patient with depletion syndrome from secretory villous adenoma.
Topics: Adenoma, Villous; Adult; Cyclooxygenase Inhibitors; Diuretics; Drug Therapy, Combination; Female; Hu | 2017 |
Shakuyaku-kanzo-to induces pseudoaldosteronism characterized by hypokalemia, rhabdomyolysis, metabolic alkalosis with respiratory compensation, and increased urinary cortisol levels.
Topics: Aged; Alkalosis; Drug Combinations; Drugs, Chinese Herbal; Electrocardiography; Female; Glycyrrhiza; | 2009 |
An unusual case of an aldosterone-producing adrenocortical adenoma presenting with rhabdomyolysis.
Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenal Glands; Adrenalectomy; Adrenocortical Adenoma; Aldoste | 2009 |
Resistant hypertension in an aged woman presenting with clinical features simulating ectopic ACTH syndrome--response to spironolactone--.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; ACTH Syndrome, Ectopic; Adrenocorticotropic Hormone; Ag | 2010 |
Gitelman's syndrome presenting as recurrent paralytic ileus due to chronic renal tubular K+ wasting.
Topics: Alkalosis; Bartter Syndrome; Calcium; Chronic Disease; Diagnosis, Differential; Diuretics; Gitelman | 2010 |
Quadriparesis in an adult--Gitelman syndrome.
Topics: Alkalosis; Calcium; Gitelman Syndrome; Humans; Hypokalemia; Magnesium; Magnesium Deficiency; Male; M | 2011 |
Gitelman syndrome: novel mutation and long-term follow-up.
Topics: Child; Diuretics; Female; Follow-Up Studies; Gitelman Syndrome; Humans; Hypokalemia; Magnesium; Muta | 2012 |
Eplerenone improved hypokalemia in a patient with Gitelman's syndrome.
Topics: Base Sequence; DNA Mutational Analysis; Eplerenone; Female; Gitelman Syndrome; Humans; Hypokalemia; | 2012 |
Gitelman syndrome.
Topics: Disease Management; General Practitioners; Gitelman Syndrome; Humans; Hypokalemia; Interprofessional | 2012 |
Hypokalemic paralysis in a middle-aged female with classic Bartter syndrome.
Topics: Bartter Syndrome; Chloride Channels; Dietary Supplements; Diuretics; Female; Genetic Predisposition | 2014 |
Apparent mineralocorticoid excess syndrome: report of one family with three affected children.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Adolescent; Child; Child, Preschool; Dietary Supplements; DNA | 2012 |
Liddle syndrome in a newborn infant.
Topics: Alkalosis; Amiloride; Blood Pressure; Diuretics; Electrolytes; Failure to Thrive; Female; Humans; Hy | 2002 |
Eplerenone in patients with left ventricular dysfunction.
Topics: Death, Sudden, Cardiac; Eplerenone; Humans; Hypokalemia; Mineralocorticoid Receptor Antagonists; Myo | 2003 |
[Aldactone as a drug controlling hypokalemia in diuretic therapy].
Topics: Diuretics; Heart Failure; Humans; Hypokalemia; Spironolactone | 1962 |
[On the treatment of decompensated liver cirrhosis with spirolactone].
Topics: Ascites; Chlorothiazide; Humans; Hypokalemia; Liver Cirrhosis; Spironolactone | 1962 |
Hypokalaemia, hypochloraemia, and baseosis in long-term treatment of oedematous heart failure with benzothiadiazine diuretics. III. Effect of spironolactone.
Topics: Acid-Base Imbalance; Alkalosis; Benzimidazoles; Chlorides; Edema; Heart Failure; Humans; Hypokalemia | 1962 |
Electrolyte complications of drug therapy.
Topics: Alkalosis; Anatomy; Carbonic Anhydrases; Diuretics; Electrolytes; Estrogens; Humans; Hypercalcemia; | 1963 |
HYPERALDOSTERONISM AND HYPERGRANULARITY OF THE JUXTAGLOMERULAR CELLS IN RENAL HYPERTENSION. METABOLIC STUDIES.
Topics: Alkalosis; Humans; Hyperaldosteronism; Hypertension, Renal; Hypokalemia; Kidney; Potassium; Renal Ar | 1963 |
THE STUDY OF THE EFFECT OF SPIROLACTONES ON ASCITES AND INTRASPLENIC PRESSURE IN BILHARZIAL LIVER CIRRHOSIS.
Topics: Animals; Ascites; Benzothiadiazines; Blood Pressure; Blood Pressure Determination; Hypokalemia; Live | 1963 |
[ENDOCRINOLOGICAL ASPECTS OF THE POTASSIUM DEPLETION SYNDROME].
Topics: Diuretics; Endocrine Glands; Heparin; Hyperaldosteronism; Hypokalemia; Liver Cirrhosis; Mineralocort | 1963 |
[WATER RETENTION IN CIRRHOTICS. PHYSIOPATHOLOGICAL DATA AND THERAPEUTIC RESULTS].
Topics: Ascites; Edema; Heart Failure; Humans; Hypokalemia; Hyponatremia; Liver Cirrhosis; Mineralocorticoid | 1963 |
VARIATIONS IN PLASMA RENIN CONCENTRATION IN SEVERAL PHYSIOLOGICAL AND PATHOLOGICAL STATES.
Topics: Addison Disease; Aldosterone; Angiotensins; Blood Chemical Analysis; Hypertension; Hypokalemia; Live | 1964 |
PRIMARY ALDOSTERONISM IN PREGNANCY.
Topics: Adolescent; Black People; Clinical Laboratory Techniques; Diagnosis, Differential; Epistaxis; Female | 1964 |
[THE TREATMENT OF EDEMA WITH SULFONAMIDE DIURETICS].
Topics: Acetazolamide; Acidosis; Benzothiadiazines; Chlorothiazide; Chlorthalidone; Dehydration; Diuretics; | 1964 |
[CHRONIC IDIOPATHIC HYPOKALEMIA WITH HYPERKALIURIA IN CHILDREN].
Topics: Adrenal Glands; Aldosterone; Blood Platelet Disorders; Blood Platelets; Child; Corticosterone; Dwarf | 1964 |
PRIMARY ALDOSTERONISM DUE TO AN ADRENAL ADENOMA IN A THREE-YEAR-OLD CHILD.
Topics: 17-Ketosteroids; Adenoma; Adrenal Cortex Hormones; Adrenal Gland Neoplasms; Adrenocortical Adenoma; | 1964 |
CLINICAL EXPERIENCE WITH A NEW DIURETIC, TRIAMTERENE, IN CONJESTIVE HEART FAILURE.
Topics: Arrhythmias, Cardiac; Canada; Chlorides; Digitalis Glycosides; Diuretics; Edema; Heart Failure; Hydr | 1964 |
A NEW EFFECTIVE DIURETIC--LASIX.
Topics: Chlorthalidone; Diuretics; Drug Therapy; Furosemide; Heart Failure; Hydrochlorothiazide; Hypokalemia | 1964 |
THE PERIODIC PARALYSES: DIFFERENTIAL FEATURES AND PATHOLOGICAL OBSERVATIONS IN PERMANENT MYOPATHIC WEAKNESS.
Topics: Acetazolamide; Drug Therapy; Epinephrine; Humans; Hydrochlorothiazide; Hydrocortisone; Hyperkalemia; | 1964 |
BILATERAL RENAL ARTERY STENOSIS WITH ALDOSTERONISM.
Topics: Angiography; Chlorides; Electrocardiography; Guanethidine; Heart Failure; Humans; Hyperaldosteronism | 1964 |
STUDIES ON ETHACRYNIC ACID IN PATIENTS WITH REFRACTORY EDEMA.
Topics: Alkalosis; Blood; Chlorides; Creatine; Creatinine; Diuretics; Drug Therapy; Edema; Ethacrynic Acid; | 1965 |
HYPOKALEMIA AND HYPERTENSION; A PRESENTATION OF FOUR CASES INCLUDING A CASE OF PRIMARY ALDOSTERONISM.
Topics: Adrenal Gland Neoplasms; Drug Therapy; Geriatrics; Heart Arrest; Humans; Hydroflumethiazide; Hyperal | 1964 |
PERIODIC PARALYSIS.
Topics: Adolescent; Chlorides; Cortisone; Diet Therapy; Diet, Sodium-Restricted; Digoxin; Drug Therapy; Gene | 1965 |
ISLET-CELL CARCINOMA (ZOLLINGER-ELLISON SYNDROME) WITH FULMINATING ADRENOCORTICAL HYPERFUNCTION AND HYPOKALEMIA.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adenoma, Islet Cell; Adrenalectomy; Adrenocortical Hyper | 1965 |
PRIMARY ALDOSTERONISM DUE TO AN ADRENAL CARCINOMA.
Topics: Adrenal Cortex Hormones; Adrenal Gland Neoplasms; Alkalosis; Blood; Drug Therapy; Hyperaldosteronism | 1965 |
[APROPOS OF A CASE OF CONN'S SYNDROME. THE DIFFERENTIAL DIAGNOSIS OF HYPERALDOSTERONISM WITH THE HELP OF DYNAMIC FUNCTION TESTS].
Topics: Albumins; Alkalosis; Angiotensins; Diagnosis, Differential; Hyperaldosteronism; Hypertension; Hypoka | 1964 |
CONN'S SYNDROME WITH ASSOCIATED PREGNANCY.
Topics: Adenoma; Adrenal Gland Neoplasms; Blood; Dexamethasone; Diagnosis; Female; Humans; Hyperaldosteronis | 1965 |
Distinction between Liddle syndrome and apparent mineralocorticoid excess.
Topics: Alkalosis; Blood Pressure; Diagnosis, Differential; Humans; Hydrocortisone; Hypertension, Renal; Hyp | 2004 |
Evaluation of high blood pressure in a 12-year-old girl.
Topics: Child; Dexamethasone; Diagnosis, Differential; Female; Glucocorticoids; Humans; Hyperaldosteronism; | 2004 |
Co-secretion of aldosterone and cortisol by an adrenocortical carcinoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aldosterone; Diuretics; Female; Histocyto | 2004 |
Hypokalemic quadriparesis with normotensive primary hyperaldosteronism.
Topics: Blood Pressure; Female; Humans; Hyperaldosteronism; Hypokalemia; Middle Aged; Mineralocorticoid Rece | 2004 |
A Korean family of hypokalemic periodic paralysis with mutation in a voltage-gated calcium channel (R1239G).
Topics: Acetazolamide; Adolescent; Arginine; Calcium Channels; Calcium Channels, L-Type; Codon; Exons; Famil | 2005 |
Clinical experience with spironolactone in pediatrics.
Topics: Chronic Disease; Diagnosis-Related Groups; Diuretics; Female; Heart Diseases; Humans; Hyperkalemia; | 2005 |
Conn's syndrome presenting as depression.
Topics: Adult; Depressive Disorder; Diagnosis, Differential; Humans; Hyperaldosteronism; Hypokalemia; Male; | 2005 |
Gitelman's syndrome presenting as intolerance to statin therapy.
Topics: Adult; Amiloride; Cholesterol; Dose-Response Relationship, Drug; Female; Humans; Hydroxymethylglutar | 2005 |
Life-threatening hypokalaemia on a low-carbohydrate diet associated with previously undiagnosed primary hyperaldosteronism [corrected].
Topics: Aldosterone; Diabetes Mellitus, Type 2; Diet, Reducing; Dietary Carbohydrates; Humans; Hypoaldostero | 2005 |
Gitelman's syndrome with silent thyroiditis.
Topics: Adult; Calcium; Female; Humans; Hypokalemia; Kidney Diseases; Magnesium; Muscular Diseases; Spironol | 2006 |
[MEN type I presenting hypokalemia and hypertension, complicated with acromegaly, adrenal cortical tumor and rectal carcinoid tumor].
Topics: Acromegaly; Adrenalectomy; Adrenocortical Adenoma; Aged; Aldosterone; Carcinoid Tumor; Female; Growt | 2006 |
Severe hypokalemia, rhabdomyolysis, muscle paralysis, and respiratory impairment in a hypertensive patient taking herbal medicines containing licorice.
Topics: Administration, Oral; Aged, 80 and over; Female; Glycyrrhiza; Humans; Hypertension; Hypokalemia; Inj | 2007 |
Eplerenone improves prognosis in postmyocardial infarction diabetic patients with heart failure: results from EPHESUS.
Topics: Aged; Clinical Trials as Topic; Diabetes Complications; Eplerenone; Female; Heart Failure; Humans; H | 2008 |
Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment.
Topics: Adrenalectomy; Aldosterone; Follow-Up Studies; Humans; Hyperaldosteronism; Hypertension; Hypokalemia | 2007 |
Tailored hormonal therapy in secretory adrenocortical cancer.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Carcinoma; Aged; Aldosterone; Alkalosis; Ang | 2007 |
[Instinctive food selection as a disease-regulating factor].
Topics: Appetite; Autonomic Nervous System; Disease; Female; Food; Humans; Hunger; Hyperaldosteronism; Hypoc | 1966 |
Secondary aldosteronism in refractory edema.
Topics: Diuretics; Drug Synergism; Edema; Heart Failure; Humans; Hyperaldosteronism; Hypokalemia; Liver Cirr | 1967 |
Bilateral adrenal hyperplasia as a cause of primary aldosteronism with hypertension, hypokalemia and suppressed renin activity.
Topics: 17-Hydroxycorticosteroids; Adrenal Gland Diseases; Adrenal Glands; Aldosterone; Blood Urea Nitrogen; | 1967 |
Differential response to thiazides and spironolactone in primary aldosteronism.
Topics: Adult; Alkalosis; Blood Pressure; Diagnosis, Differential; Humans; Hydrochlorothiazide; Hyperaldoste | 1967 |
Apparent mineralocorticoid excess and deficient 11 beta-oxidation of cortisol in a young female.
Topics: Adrenocorticotropic Hormone; Adult; Alkalosis; Amiloride; Aminoglutethimide; Dexamethasone; Drug The | 1984 |
Pure primary hyperaldosteronism due to adrenal cortical carcinoma.
Topics: Adrenal Cortex Neoplasms; Calcinosis; Carcinoma; Female; Humans; Hyperaldosteronism; Hypertension; H | 1984 |
A possible role of hypokalemia in the manifestation of high QRS voltage and sinus bradycardia in patients with primary aldosteronism.
Topics: Adult; Blood Pressure; Bradycardia; Electrocardiography; Female; Humans; Hyperaldosteronism; Hyperte | 1984 |
[Development of tetany in siblings suffered from Bartter's syndrome].
Topics: Adult; Bartter Syndrome; Biopsy; Calcium; Female; Humans; Hyperaldosteronism; Hypokalemia; Kidney; M | 1984 |
Primary aldosteronism is comprised of primary adrenal hyperplasia and adenoma.
Topics: Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenalectomy; Adrenocortical Hyperfunction; Adult; Ag | 1984 |
[Hypokalemic paralysis in a case with hyperthyroidism and idiopathic hyperaldosteronism].
Topics: Female; Humans; Hyperaldosteronism; Hyperthyroidism; Hypokalemia; Middle Aged; Paralysis; Periodicit | 1983 |
A case of pseudoaldosteronism due to addiction of Jintan, a mouth refresher popular among Japanese.
Topics: Captopril; Glycyrrhetinic Acid; Humans; Hyperaldosteronism; Hypertension; Hypokalemia; Male; Middle | 1982 |
Drug attributed alterations in potassium handling in congestive cardiac failure.
Topics: Adult; Aged; Blood Urea Nitrogen; Diuretics; Female; Furosemide; Heart Failure; Humans; Hyperkalemia | 1982 |
[Therapy of cardiac insufficiency with diuretics].
Topics: Amiloride; Benzothiadiazines; Blood Glucose; Diuretics; Drug Administration Schedule; Female; Furose | 1982 |
The mechanism underlying chlorthalidone-induced hypokalaemia: effects of sodium restriction, potassium suppletion, spironolactone, and triamterene.
Topics: Adult; Chlorthalidone; Diet, Sodium-Restricted; Humans; Hypokalemia; Male; Potassium; Spironolactone | 1982 |
Metabolic alkalosis in identical twins receiving a low-chloride formula (pseudo-Bartter's syndrome).
Topics: Alkalosis; Chlorides; Diseases in Twins; Female; Hematuria; Humans; Hypokalemia; Infant Food; Potass | 1980 |
[Value of successive use of aldactone and aldactacine in the management of congestive heart failure involving at the outset hypokalemia with or without cardiac rhythm disorders].
Topics: Adult; Aged; Arrhythmias, Cardiac; Drug Combinations; Female; Heart Failure; Humans; Hypokalemia; Ma | 1981 |
Effect of indomethacin in two siblings with a renin-dependent hypertension, hyperaldosteronism and hypokalemia.
Topics: Adolescent; Adult; Angiotensin II; Drug Therapy, Combination; Female; Humans; Hyperaldosteronism; Hy | 1980 |
Amiloride, spironolactone, and potassium chloride in thiazide-treated hypertensive patients.
Topics: Adult; Aldosterone; Amiloride; Angiotensin II; Bendroflumethiazide; Bicarbonates; Blood Pressure; Di | 1980 |
Edema associated with laxative abuse and excessive diuretic therapy.
Topics: Adult; Cathartics; Diet, Sodium-Restricted; Diuretics; Edema; Ethacrynic Acid; Female; Foot Diseases | 1980 |
Correction of hypokalemia with antialdosterone therapy in Gitelman's syndrome.
Topics: Adult; Aldosterone; Amiloride; Bartter Syndrome; Blood Gas Analysis; Blood Pressure; Creatinine; Dru | 1994 |
Primary hyperaldosteronism--diagnostic approach and management.
Topics: Adult; Female; Follow-Up Studies; Humans; Hyperaldosteronism; Hypokalemia; Male; Middle Aged; Nifedi | 1993 |
[Hypokalemic metabolic alkalosis with hypomagnesemia and hypocalciuria; Bartter's syndrome in Gitelman's variant--case report].
Topics: Adult; Alkalosis; Bartter Syndrome; Humans; Hypokalemia; Indomethacin; Magnesium; Male; Potassium; P | 1995 |
A case of Gitelman's syndrome with chondrocalcinosis.
Topics: Bartter Syndrome; Calcium; Chondrocalcinosis; Diagnosis, Differential; Female; Humans; Hypokalemia; | 1998 |
Drugs for chronic heart failure.
Topics: Adrenergic beta-Antagonists; Angioedema; Angiotensin Receptor Antagonists; Angiotensin-Converting En | 1999 |
Bilateral vocal fold paralysis caused by familial hypokalemic periodic paralysis.
Topics: Adult; Diuretics; Dyspnea; Exercise Test; Female; Humans; Hypokalemia; Paralyses, Familial Periodic; | 1999 |
Comment: spironolactone prevents amphotericin B-induced hypokalemia in neutropenic patients.
Topics: Amphotericin B; Drug Interactions; Humans; Hypokalemia; Mineralocorticoid Receptor Antagonists; Neut | 2000 |
A family with liddle's syndrome caused by a mutation in the beta subunit of the epithelial sodium channel.
Topics: Aldosterone; Alkalosis; Base Sequence; Blood Gas Analysis; Calcium Channel Blockers; Diagnosis, Diff | 2001 |
Normokalemic hyperaldosteronism in patients with resistant hypertension.
Topics: Adult; Aged; Aldosterone; Analysis of Variance; Antihypertensive Agents; Creatinine; Female; Humans; | 2002 |
Primary aldosteronism: the most frequent form of secondary hypertension?
Topics: Aldosterone; Antihypertensive Agents; Humans; Hyperaldosteronism; Hypertension; Hypokalemia; Mineral | 2002 |
Hypertension, hypokalemia, hyporeninemia and severe target organ damage.
Topics: Aldosterone; Blood Pressure; Cardiomegaly; Female; Humans; Hyperaldosteronism; Hypertension; Hypokal | 1976 |
Hypokalemic periodic paralysis.
Topics: Adolescent; Humans; Hydrochlorothiazide; Hypokalemia; Male; Paralyses, Familial Periodic; Potassium | 1979 |
[Basis and clinical aspects of diuretic drug therapy].
Topics: Acetazolamide; Benzothiadiazines; Diuretics; Edema; Edema, Cardiac; Furosemide; Glaucoma; Humans; Hy | 1979 |
Mitotane. Spironolactone antagonism in Cushing's syndrome.
Topics: Aged; Cushing Syndrome; Diarrhea; Female; Humans; Hypokalemia; Mitotane; Nausea; Spironolactone | 1977 |
Management of hepatic ascites.
Topics: Ascites; Diuresis; Drainage; Humans; Hypokalemia; Liver Diseases; Spironolactone | 1978 |
Potassium-level changes during long-term thiazide therapy.
Topics: Heart Failure; Humans; Hypertension; Hypokalemia; Magnesium; Potassium; Potassium Chloride; Spironol | 1978 |
[Bartter's syndrome, with limited response to adrenalectomy].
Topics: Adrenalectomy; Adult; Bartter Syndrome; Female; Humans; Hyperaldosteronism; Hypokalemia; Juxtaglomer | 1978 |
Diuretics in the treatment of hypertension.
Topics: Benzothiadiazines; Diuretics; Humans; Hyperglycemia; Hypertension; Hypokalemia; Sodium Chloride Symp | 1978 |
Hypophosphatemia and hyperparathyroidism in a case of Bartter's syndrome.
Topics: Adolescent; Alkalosis; Bartter Syndrome; Humans; Hyperaldosteronism; Hyperparathyroidism; Hypokalemi | 1978 |
Asymptomatic Bartter's syndrome.
Topics: Angiotensin II; Bartter Syndrome; Drug Therapy, Combination; Humans; Hyperaldosteronism; Hypokalemia | 1978 |
The role of potassium-canrenoate on 3H-noradrenaline uptake and metabolism of the rat heart.
Topics: Animals; Canrenoic Acid; Hypokalemia; Myocardial Contraction; Myocardium; Norepinephrine; Pargyline; | 1978 |
Paroxysmal atrial fibrillation with asystole and syncope: report of a case of sinus node dysfunction with hypokalemia and hypertension.
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Heart Arrest; Humans; Hypertension; Hypokalemia; Male; Mi | 1976 |
Bartter's syndrome with hyperplasia of renomedullary cells: successful treatment with indomethacin.
Topics: Adult; Bartter Syndrome; Body Weight; Dose-Response Relationship, Drug; Humans; Hyperaldosteronism; | 1976 |
A guide to the practical use of diuretics.
Topics: Administration, Oral; Diuretics; Edema; Furosemide; Humans; Hypercalcemia; Hyperglycemia; Hypertensi | 1976 |
Editorial: Diuretics.
Topics: Diuretics; Drug Therapy, Combination; Ear Diseases; Ethacrynic Acid; Furosemide; Hypokalemia; Potass | 1975 |
Some aspects of diuretic therapy.
Topics: Aged; Amiloride; Benzothiadiazines; Digitalis Glycosides; Diuretics; Drug Therapy, Combination; Etha | 1975 |
Two cases of pseudoaldosteronism (Liddle's syndrome) in siblings.
Topics: Adolescent; Blood Pressure; Dexamethasone; Diagnosis, Differential; Female; Humans; Hyperaldosteroni | 1975 |
Spironolactone, a reassessment.
Topics: Diuresis; Drug Combinations; Humans; Hydrochlorothiazide; Hyperaldosteronism; Hypertension; Hypokale | 1975 |
Therapy of hypokalemia.
Topics: Administration, Oral; Humans; Hypokalemia; Infusions, Parenteral; Potassium Chloride; Spironolactone | 1976 |
Twenty-four year spironolactone therapy in an aged patient with aldosterone-producing adenoma.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenocorticotropic Hormone; Aged; Aldosterone; Fe | 1992 |
[Gitelman's tubulopathy: deficit of K/Mg transfer].
Topics: Acidosis, Renal Tubular; Child; Humans; Hypokalemia; Magnesium; Male; Metabolism, Inborn Errors; Pot | 1992 |
[A case of pseudohypoparathyroidism (PHP) type II associated with Bartter's syndrome--restoration of phosphaturic response to parathyroid hormone (PTH) by treatment for hypopotassemia].
Topics: Adult; Bartter Syndrome; Female; Humans; Hydroxycholecalciferols; Hypokalemia; Parathyroid Hormone; | 1992 |
Giant negative U waves in a patient with uncontrolled hypertension and severe hypokalemia.
Topics: Aged; Chronic Disease; Combined Modality Therapy; Drug Therapy, Combination; Electrocardiography; Fe | 1992 |
A neonate with idiopathic hyperaldosteronism.
Topics: Aldosterone; Calcium; Gastrointestinal Diseases; Humans; Hyperaldosteronism; Hypokalemia; Infant, Ne | 1991 |
[Kidney tubular transport disorders. Liddle's syndrome].
Topics: Dexamethasone; Diagnosis, Differential; Female; Humans; Hypertension; Hypoaldosteronism; Hypokalemia | 1989 |
New findings in apparent mineralocorticoid excess.
Topics: Adrenocorticotropic Hormone; Aldosterone; Child; Child, Preschool; Cortisone; Female; Humans; Hydroc | 1987 |
Spironolactone-reversible rickets associated with 11 beta-hydroxysteroid dehydrogenase deficiency syndrome.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Adrenocorticotropic Hormone; Aldosterone; Alkalosis; Bone and | 1986 |
[Acute reversible kidney insufficiency due to enalapril during diuretic-treated heart insufficiency].
Topics: Acute Kidney Injury; Adult; Drug Therapy, Combination; Enalapril; Female; Heart Failure; Humans; Hyp | 1987 |
[Restoration of insulin sensitivity after correction of hypokalemia due to chronic tubulopathy in a diabetic patient].
Topics: Adult; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glucose Clamp Technique; Humans; H | 1988 |
Potassium-sparing diuretics.
Topics: Amiloride; Diuretics; Heart Failure; Humans; Hypokalemia; Magnesium Deficiency; Potassium; Spironola | 1986 |
Apparent mineralocorticoid excess causing hypertension and hypokalemia in children.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Aldosterone; Child; Child, Preschool; Female; Humans; Hydroco | 1986 |
What's new in diuretic therapy.
Topics: Acetazolamide; Acid-Base Imbalance; Biological Transport; Diuretics; Drug Resistance; Ethacrynic Aci | 1986 |
Potassium loss, ventricular irritability, and the risk of sudden death in hypertensive patients.
Topics: Amiloride; Arrhythmias, Cardiac; Death, Sudden; Diuretics; Humans; Hypertension; Hypokalemia; Magnes | 1986 |
Blood to interstitial fluid volume ratio in chronic hypokalaemic states.
Topics: Bartter Syndrome; Blood Volume; Chlorthalidone; Chronic Disease; Extracellular Space; Female; Humans | 1985 |
[Principles of treating hypertension patients with diuretics].
Topics: Absorption; Amiloride; Benzothiadiazines; Blood Pressure; Diuresis; Diuretics; Drug Resistance; Huma | 1986 |
Hypokalemic paralysis in Sjögren's syndrome secondary to renal tubular acidosis.
Topics: Acidosis, Renal Tubular; Bicarbonates; Female; Humans; Hypokalemia; Middle Aged; Paralysis; Potassiu | 1985 |
Arrhythmogenic potential of diuretic induced hypokalaemia in patients with mild hypertension and ischaemic heart disease.
Topics: Amiloride; Arrhythmias, Cardiac; Chlorthalidone; Coronary Disease; Cyclopenthiazide; Diuretics; Fema | 1985 |
Hypertension with aldosterone excess and low plasma-renin: preoperative distinction between patients with and without adrenocortical tumour.
Topics: Adenoma; Adolescent; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Age Fac | 1970 |
Apparently isolated excess deoxycorticosterone in hypertension. A variant of the mineralocorticoid-excess syndrome.
Topics: 17-Ketosteroids; Adult; Aged; Aldosterone; Chromatography, Gas; Desoxycorticosterone; Dexamethasone; | 1972 |
Functional black adenoma of the adrenal cortex. A rare cause of primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Dexamethasone; Female; Histocytochemistry; Humans; Hyperald | 1974 |
Complications of diuretic therapy in hepatic cirrhosis.
Topics: Chlorothiazide; Diuretics; Ethacrynic Acid; Furosemide; Hepatic Encephalopathy; Humans; Hypokalemia; | 1966 |
Amiloride ('MK 870') in patients with ascites due to cirrhosis of the liver.
Topics: Adult; Ascites; Bicarbonates; Creatinine; Diuretics; Ethacrynic Acid; Furosemide; Guanidines; Humans | 1968 |
Direct current cardioversion in digitalized patients with mitral valve disease.
Topics: Adult; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Bradycardia; Cardiac Complexes, Pr | 1969 |
[Bartter syndrome. Vascular angiotensin II resistance with juxtaglomerular cellular hyperplasia and hyperaldosteronism].
Topics: Adult; Angiotensin II; Humans; Hyperaldosteronism; Hyperplasia; Hypokalemia; Kidney Diseases; Potass | 1965 |
Normotensive secondary hyperaldosteronism.
Topics: Adult; Aldosterone; Angiotensin II; Blood Pressure; Child, Preschool; Diet Therapy; Dwarfism; Female | 1966 |
Hypokalaemic alkalosis and hyperplasia of the juxtaglomerular apparatus without hypertension or oedema.
Topics: Adolescent; Alkalosis; Angiotensin II; Blood Pressure; Extracellular Space; Humans; Hyperaldosteroni | 1967 |
Primary periodic paralysis associated with hyperkalemic and hypokalemic attacks and with hemolytic bilirubinemia.
Topics: Acetazolamide; Adolescent; Adrenocorticotropic Hormone; Adult; Aldosterone; Bilirubin; Dexamethasone | 1968 |
[Disorders of water-electrolyte metabolism associated with decompensated cirrhosis. The danger of various therapeutic drugs].
Topics: Acute Kidney Injury; Adult; Aged; Ascites; Blood Transfusion; Blood Urea Nitrogen; Blood Volume Dete | 1968 |
[Differential diagnosis of the Bartter syndrome].
Topics: Adult; Aldosterone; Alkalosis; Angiotensin II; Biopsy; Chymosin; Diagnosis, Differential; Female; Hu | 1968 |
Pathogenesis of Bartter's syndrome.
Topics: Adrenal Gland Diseases; Adrenocorticotropic Hormone; Albumins; Aldosterone; Alkalosis; Angiotensin I | 1969 |
[Chronic idiopathic hypokalemia with hyperkaliuria in a very young infant. (Bioclinical and histological study)].
Topics: Aldosterone; Alkalosis; Angiotensin II; Calcium; Chlorides; Diet, Sodium-Restricted; Growth Disorder | 1969 |
Bartter's syndrome. A report of four cases, including three in one sibship, with comparative histologic evaluation of the juxtaglomerular apparatuses and glomeruli.
Topics: Alkalosis; Angiotensin II; Blood Pressure; Carbon Dioxide; Cerebrospinal Fluid Proteins; Electrolyte | 1970 |
An unusual type of hypokalaemic alkalosis with a disturbance of renin and aldosterone.
Topics: Adolescent; Adrenal Cortex Hormones; Albumins; Aldosterone; Alkalosis; Angiotensin II; Creatinine; D | 1970 |
Case studies of siblings with juxtaglomerular hyperplasia and secondary aldosteronism associated with severe azotemia and renal rickets--Bartter's syndrome or disease?
Topics: Aldosterone; Alkalosis; Angiotensin II; Bone Diseases; Child; Child, Preschool; Humans; Hyperaldoste | 1970 |
[The renin-angiotensin-aldosterone system. Disorders and methods of clinical research].
Topics: Adrenal Gland Neoplasms; Adrenal Insufficiency; Aldosterone; Angiotensin II; Dexamethasone; Electrol | 1970 |
Low renin hypertension and the adrenal cortex.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Adult; Aldosterone; Angiotensin II; Blood Pressure; Cor | 1972 |
Six year follow-up of a child with Bartter syndrome.
Topics: Aldosterone; Alkalosis; Angiotensin II; Biopsy; Blood Pressure; Child, Preschool; Diet Therapy; Fema | 1973 |
Some observations on the pathogenesis of Bartter's syndrome.
Topics: Adult; Aldosterone; Alkalosis; Angiotensin II; Blood Volume; Drug Therapy, Combination; Humans; Hype | 1973 |
Renin-angiotensin-aldosterone system of a woman with Bartter's syndrome: Juxtaglomerular cell hyperplasia without hypertension.
Topics: Adult; Aldosterone; Angiotensin II; Diet, Sodium-Restricted; Female; Humans; Hyperaldosteronism; Hyp | 1974 |
The role of mineralocorticoids in the pathogenesis of hypokalemic periodic paralysis.
Topics: Adult; Aldosterone; Angiotensin II; Desoxycorticosterone; Humans; Hydrocortisone; Hyperaldosteronism | 1974 |
[A description of a case of Conn's syndrome (author's transl)].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Adult; Aortography; Female; Humans; | 1974 |
[Severe hypokalemia with tetraplegia due to laxative abuse. Clinical, histological and ultrastructural study (2 cases)].
Topics: Adult; Cathartics; Constipation; Female; Humans; Hypokalemia; Male; Muscles; Potassium; Potassium Ch | 1974 |
[Bartter's syndrome in adults. Case report with light- and electron-microscopic findings].
Topics: Adult; Alkalosis; Female; Humans; Hyperaldosteronism; Hyperplasia; Hypertrophy; Hypokalemia; Hypoten | 1973 |
Clinical use of potassium supplements and potassium sparing diuretics.
Topics: Aldosterone; Amiloride; Diuretics; Drug Therapy, Combination; Humans; Hyperkalemia; Hypokalemia; Kid | 1973 |
Urologic considerations in Bartter's syndrome.
Topics: Adolescent; Adult; Biopsy; Carpal Bones; Female; Foot; Humans; Hydronephrosis; Hyperaldosteronism; H | 1974 |
Editorial: Drugs for gastric ulceration.
Topics: Bismuth; Cholestyramine Resin; Diethylstilbestrol; Diuresis; Dose-Response Relationship, Drug; Glycy | 1974 |
Diuretics and hypokalaemia: aldosterone antagonists or potassium supplementation?
Topics: Administration, Oral; Diuretics; Humans; Hypokalemia; Mineralocorticoid Receptor Antagonists; Potass | 1974 |
[Electrocardiographic observations in secondary aldosteronism].
Topics: Aged; Aldosterone; Body Weight; Digitalis Glycosides; Diuresis; Electrocardiography; Female; Heart F | 1972 |
[Problems in Bartter's syndrome].
Topics: Alkalosis; Biopsy; Child, Preschool; Female; Glomerular Filtration Rate; Humans; Hyperaldosteronism; | 1971 |
Use of metolazone in the treatment of ascites due to liver disease.
Topics: Adult; Ascites; Chlorides; Chronic Disease; Diuretics; Female; Hepatic Encephalopathy; Humans; Hypok | 1971 |
[Diuresis and diuretics].
Topics: Acetazolamide; Acute Disease; Agranulocytosis; Anuria; Biological Transport; Blood Platelet Disorder | 1971 |
[Hypokalemias and their myocardial disorders].
Topics: Arrhythmias, Cardiac; Diagnosis, Differential; Digitalis Glycosides; Electrocardiography; Heart; Hum | 1971 |
Chronic hypokalaemia with growth retardation, normotensive hyperrenin-hyperaldosteronism ("Bartter's syndrome"), and hypercalciuria. Report of two cases with emphasis on natural history and on catch-up growth during treatment.
Topics: Alkalosis; Calcium; Child; Chronic Disease; Female; Growth Disorders; Humans; Hyperaldosteronism; Hy | 1971 |
The complications of diuretic therapy in patients with cirrhosis.
Topics: Alkalosis; Ascites; Blood Urea Nitrogen; Chlorothiazide; Ethacrynic Acid; Furosemide; Hepatic Enceph | 1966 |
Drug-induced secondary hyperaldosteronism in patients with pulmonary tuberculosis.
Topics: Adult; Aldosterone; Female; Gentamicins; Humans; Hyperaldosteronism; Hypokalemia; Magnesium; Male; M | 1970 |
The new diuretics.
Topics: Acetazolamide; Chlorothiazide; Diuresis; Diuretics; Edema; Ethacrynic Acid; Furosemide; Humans; Hypo | 1970 |
[Hypokalemia, myopathy with myoglobinuria after prolonged ingestion of licorice].
Topics: Adult; Alkalosis; Glycyrrhiza; Humans; Hypokalemia; Male; Muscular Dystrophies; Myoglobinuria; Plant | 1970 |
Clinical usage of the newer diuretic agents.
Topics: Diuretics; Ethacrynic Acid; Furosemide; Humans; Hypokalemia; Kidney Diseases; Spironolactone; Triamt | 1970 |
Erythrocyte Na flux in a patient with Bartter's syndrome.
Topics: Aldosterone; Alkalosis; Ammonium Chloride; Biological Transport; Biological Transport, Active; Cell | 1971 |
[Endocrinologic and circulatory findings in a case of primary aldosteronism].
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Female; Hemodynamics; Humans; Hyperaldosteronism; Hyp | 1971 |
High dose frusemide in the treatment of hypertension in chronic renal insufficiency and of terminal renal failure.
Topics: Adolescent; Adult; Creatine; Creatinine; Diuresis; Female; Furosemide; Gout; Humans; Hypertension, R | 1971 |
Urinary citrate excretion in primary aldosteronism.
Topics: Addison Disease; Adult; Aldosterone; Carbon Dioxide; Citrates; Desoxycorticosterone; Dexamethasone; | 1967 |
[Periodic paralyses].
Topics: Adrenal Insufficiency; Adult; Humans; Hyperaldosteronism; Hyperthyroidism; Hypokalemia; Male; Muscle | 1967 |
[Hypokalemic ileus and aldosteronism].
Topics: Adolescent; Aged; Humans; Hyperaldosteronism; Hypokalemia; Iatrogenic Disease; Injections, Intraveno | 1967 |
[2 cases of Cushing's disease with a hypokalemic alkalosis syndrome].
Topics: Adrenalectomy; Adult; Alkalosis; Calcium; Cushing Syndrome; Female; Humans; Hypokalemia; Metyrapone; | 1967 |
[A case of juvenile arterial hypertension associated with hypokalemia and low aldosterone secretion (Liddle syndrome)].
Topics: Adolescent; Aldosterone; Female; Humans; Hypertension; Hypokalemia; Spironolactone; Triamterene | 1968 |
[Diagnosis and therapy of glycoside intoxication].
Topics: Cardiac Glycosides; Electrocardiography; Humans; Hypokalemia; Potassium; Spironolactone; Triamterene | 1968 |
[Kidney artery stenosis, renal hypertension and secondary hyperaldosteronism in an 8-year-old boy. (Stunted growth through potassium deficiency)].
Topics: Adrenal Glands; Aldosterone; Child; Dwarfism; Humans; Hyperaldosteronism; Hypertension, Renal; Hypok | 1968 |
Potassium losing pyelonephritis. Response to spironolactone.
Topics: Aged; Diet Therapy; Humans; Hyperaldosteronism; Hypokalemia; Male; Peptic Ulcer; Potassium; Potassiu | 1969 |
[Primary hyperaldosteronism. Description of a clinical case].
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Gland Neoplasms; Adult; Alkalosis; Electrolytes; | 1969 |
[Diuretics in cirrhosis. Accidents. Indications].
Topics: Adrenal Cortex Hormones; Alkalosis; Blood Urea Nitrogen; Blood Volume; Diuretics; Edema; Ethacrynic | 1969 |
Diuretics. II. Other drugs.
Topics: Drug Synergism; Ethacrynic Acid; Furosemide; Humans; Hypokalemia; Spironolactone; Triamterene | 1969 |
[Tetraplegia caused by hypokalemia].
Topics: Adult; Diet, Sodium-Restricted; Humans; Hypokalemia; Male; Paralyses, Familial Periodic; Potassium; | 1969 |
Plasma renin activity in the diagnosis of primary aldosteronism: failure to distinguish primary aldosteronism from essential hypertension.
Topics: Adrenal Gland Neoplasms; Adult; Aldosterone; Animals; Biological Assay; Blood Urea Nitrogen; Chlorot | 1969 |
Clinical studies on the acid-base balance disturbance in congestive heart failure.
Topics: Acid-Base Equilibrium; Acidosis, Respiratory; Adult; Aldosterone; Alkalosis; Arteries; Benzothiadiaz | 1969 |
Conn's syndrome due to adrenal hyperplasia with hypertrophy of zona glomerulosa, relieved by unilateral adrenalectomy.
Topics: Adrenal Gland Diseases; Adrenalectomy; Adult; Alkalosis; Humans; Hydrocortisone; Hyperaldosteronism; | 1965 |
A new familial disorder characterized by hypokalemia and hypomagnesemia.
Topics: Adult; Diet Therapy; Erythema; Female; Humans; Hypokalemia; Magnesium; Magnesium Deficiency; Middle | 1966 |
Primary aldosteronism due to adrenocortical adenoma (Conn's syndrome).
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Female; Humans; Hyperaldosteronism; Hypokalemia; Paralysis; | 1966 |
Studies in familial hypokalaemic periodic paralysis.
Topics: Adult; Aldosterone; Blood Chemical Analysis; Chlorides; Diet, Sodium-Restricted; Diuresis; Electroly | 1966 |